<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-id journal-id-type="iso-abbrev">Environ. Health Perspect</journal-id><journal-title-group><journal-title>Environmental Health Perspectives</journal-title></journal-title-group><issn pub-type="ppub">0091-6765</issn><issn pub-type="epub">1552-9924</issn><publisher><publisher-name>National Institute of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20075020</article-id><article-id pub-id-type="pmc">2898847</article-id><article-id pub-id-type="doi">10.1289/ehp.0901416</article-id><article-id pub-id-type="publisher-id">ehp-118-735</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Do TETRA (Airwave) Base Station Signals Have a Short-Term Impact on Health and Well-Being? A Randomized Double-Blind Provocation Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wallace</surname><given-names>Denise</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref></contrib><contrib contrib-type="author"><name><surname>Eltiti</surname><given-names>Stacy</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref><xref ref-type="author-notes" rid="fn1-ehp-118-735">*</xref></contrib><contrib contrib-type="author"><name><surname>Ridgewell</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref></contrib><contrib contrib-type="author"><name><surname>Garner</surname><given-names>Kelly</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref></contrib><contrib contrib-type="author"><name><surname>Russo</surname><given-names>Riccardo</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref></contrib><contrib contrib-type="author"><name><surname>Sepulveda</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="af2-ehp-118-735">2</xref></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>Stuart</given-names></name><xref ref-type="aff" rid="af3-ehp-118-735">3</xref></contrib><contrib contrib-type="author"><name><surname>Quinlan</surname><given-names>Terence</given-names></name><xref ref-type="aff" rid="af3-ehp-118-735">3</xref></contrib><contrib contrib-type="author"><name><surname>Dudley</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="af4-ehp-118-735">4</xref></contrib><contrib contrib-type="author"><name><surname>Maung</surname><given-names>Sithu</given-names></name><xref ref-type="aff" rid="af5-ehp-118-735">5</xref></contrib><contrib contrib-type="author"><name><surname>Deeble</surname><given-names>Roger</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref></contrib><contrib contrib-type="author"><name><surname>Fox</surname><given-names>Elaine</given-names></name><xref ref-type="aff" rid="af1-ehp-118-735">1</xref><xref ref-type="corresp" rid="c1-ehp-118-735"></xref></contrib></contrib-group><aff id="af1-ehp-118-735"><label>1</label> Department of Psychology and Centre for Brain Science</aff><aff id="af2-ehp-118-735"><label>2</label> Department of Computer Science and Electronic Engineering and</aff><aff id="af3-ehp-118-735"><label>3</label> Department of Electronic Systems Engineering, University of Essex, Colchester, United Kingdom</aff><aff id="af4-ehp-118-735"><label>4</label> Department of Electrical, Computer and Communications Engineering, South Bank University, London, United Kingdom</aff><aff id="af5-ehp-118-735"><label>5</label> Lensfield Medical Practice, Cambridge, United Kingdom</aff><author-notes><corresp id="c1-ehp-118-735">Address correspondence to E. Fox, Department of Psychology and Centre for Brain Science, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, Essex, UK. Telephone: 44-0-1206873784. Fax: 44-0-1206 873801. E-mail: 
<email>efox@essex.ac.uk</email>.</corresp><fn id="fn1-ehp-118-735"><label>*</label><p>Current address: Rosemead School of Psychology, Biola University, 13800 Biola Ave., La Mirada, CA 90639 USA.</p></fn><fn><p>The authors declare they have no actual or potenetial competing financial interests.</p></fn></author-notes><pub-date pub-type="ppub"><month>6</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>14</day><month>1</month><year>2010</year></pub-date><volume>118</volume><issue>6</issue><fpage>735</fpage><lpage>741</lpage><history><date date-type="received"><day>3</day><month>9</month><year>2009</year></date><date date-type="accepted"><day>14</day><month>1</month><year>2010</year></date></history><permissions><copyright-year>2010</copyright-year><license xlink:href="http://creativecommons.org/publicdomain/mark/1.0/" license-type="public-domain"><license-p>Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. </license-p></license></permissions><abstract><sec><title><offsets xml_i="5691" xml_f="5701" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="5712" xml_f="6180" txt_i="22" txt_f="490">“Airwave” is the new communication system currently being rolled out across the United Kingdom for the police and emergency services, based on the Terrestrial Trunked Radio Telecommunications System (TETRA). Some police officers have complained about skin rashes, nausea, headaches, and depression as a consequence of using their Airwave handsets. In addition, a small subgroup in the population self-report being sensitive to electromagnetic fields (EMFs) in general.</offsets></p></sec><sec><title><offsets xml_i="6202" xml_f="6212" txt_i="492" txt_f="502">Objectives</offsets></title><p><offsets xml_i="6223" xml_f="6493" txt_i="503" txt_f="773">We conducted a randomized double-blind provocation study to establish whether short-term exposure to a TETRA base station signal has an impact on the health and well-being of individuals with self-reported “electrosensitivity” and of participants who served as controls.</offsets></p></sec><sec><title><offsets xml_i="6515" xml_f="6522" txt_i="775" txt_f="782">Methods</offsets></title><p><offsets xml_i="6533" xml_f="7001" txt_i="783" txt_f="1251">Fifty-one individuals with self-reported electrosensitivity and 132 age- and sex-matched controls participated in an open provocation test; 48 sensitive and 132 control participants went on to complete double-blind tests in a fully screened semianechoic chamber. Heart rate, skin conductance, and blood pressure readings provided objective indices of short-term physiological response. Visual analog scales and symptom scales provided subjective indices of well-being.</offsets></p></sec><sec><title><offsets xml_i="7023" xml_f="7030" txt_i="1253" txt_f="1260">Results</offsets></title><p><offsets xml_i="7041" xml_f="7486" txt_i="1261" txt_f="1706">We found no differences on any measure between TETRA and sham (no signal) under double-blind conditions for either controls or electrosensitive participants, and neither group could detect the presence of a TETRA signal at rates greater than chance (50%). When conditions were not double blind, however, the self-reported electrosensitive individuals did report feeling worse and experienced more severe symptoms during TETRA compared with sham.</offsets></p></sec><sec><title><offsets xml_i="7508" xml_f="7519" txt_i="1708" txt_f="1719">Conclusions</offsets></title><p><offsets xml_i="7530" xml_f="7725" txt_i="1720" txt_f="1915">Our findings suggest that the adverse symptoms experienced by electrosensitive individuals are due to the belief of harm from TETRA base stations rather than to the low-level EMF exposure itself.</offsets></p></sec></abstract><kwd-group><kwd>electromagnetic fields</kwd><kwd>electromagnetic hypersensitivity</kwd><kwd>electrosensitivity</kwd><kwd>idiopathic environmental intolerance</kwd><kwd>mobile phone</kwd></kwd-group></article-meta></front><body><p><offsets xml_i="7976" xml_f="8592" txt_i="1924" txt_f="2540">“Airwave” is the new communication system currently being rolled out across the United Kingdom for the police and emergency services. It is based on Terrestrial Trunked Radio Telecommunications System (TETRA), which offers enhanced digital communication that improves emergency services’ performance and public safety. However, a growing number of concerns have been raised about the possible adverse health effects related to this new technology. For example, some police officers have complained about skin rashes, nausea, sleeplessness, headaches, and depression as a consequence of using their Airwave handsets (</offsets><xref rid="b10-ehp-118-735" ref-type="bibr"><offsets xml_i="8636" xml_f="8647" txt_i="2540" txt_f="2551">Farrel 2002</offsets></xref><offsets xml_i="8654" xml_f="8656" txt_i="2551" txt_f="2553">; </offsets><xref rid="b22-ehp-118-735" ref-type="bibr"><offsets xml_i="8700" xml_f="8727" txt_i="2553" txt_f="2580">Police Federation News 2005</offsets></xref><offsets xml_i="8734" xml_f="9302" txt_i="2580" txt_f="3148">). Others have complained about unusual symptoms, which they attribute specifically to TETRA base station signals. In addition, there is a small subgroup of persons in the general population who believe they suffer from “electrosensitivity.” As the term suggests, sufferers believe that their symptoms are caused by devices emitting electromagnetic fields (EMFs), and anecdotal evidence points to TETRA as the source of some of these symptoms. Prevalence rates for self-reported electrosensitivity vary. For example, in Iran the prevalence rate is “considerably low” (</offsets><xref rid="b20-ehp-118-735" ref-type="bibr"><offsets xml_i="9346" xml_f="9367" txt_i="3148" txt_f="3169">Mortazavi et al. 2007</offsets></xref><offsets xml_i="9374" xml_f="9409" txt_i="3169" txt_f="3204">), whereas in Germany it is 10.3% (</offsets><xref rid="b5-ehp-118-735" ref-type="bibr"><offsets xml_i="9452" xml_f="9472" txt_i="3204" txt_f="3224">Blettner et al. 2009</offsets></xref><offsets xml_i="9479" xml_f="9529" txt_i="3224" txt_f="3274">). Sufferers complain of reduced quality of life (</offsets><xref rid="b14-ehp-118-735" ref-type="bibr"><offsets xml_i="9573" xml_f="9584" txt_i="3274" txt_f="3285">Irvine 2005</offsets></xref><offsets xml_i="9591" xml_f="9755" txt_i="3285" txt_f="3449">) and report poorer health and well-being compared with people without “idiopathic environmental intolerance with attribution to electromagnetic fields” (IEI-EMF) (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="9798" xml_f="9817" txt_i="3449" txt_f="3468">Eltiti et al. 2007a</offsets></xref><offsets xml_i="9824" xml_f="9940" txt_i="3468" txt_f="3584">). Some evidence indicates a possible general autonomic nervous system dysfunction in electrosensitive individuals (</offsets><xref rid="b17-ehp-118-735" ref-type="bibr"><offsets xml_i="9984" xml_f="10003" txt_i="3584" txt_f="3603">Lyskov et al. 2001a</offsets></xref><offsets xml_i="10010" xml_f="10012" txt_i="3603" txt_f="3605">, </offsets><xref rid="b18-ehp-118-735" ref-type="bibr"><offsets xml_i="10056" xml_f="10061" txt_i="3605" txt_f="3610">2001b</offsets></xref><offsets xml_i="10068" xml_f="10070" txt_i="3610" txt_f="3612">; </offsets><xref rid="b27-ehp-118-735" ref-type="bibr"><offsets xml_i="10114" xml_f="10135" txt_i="3612" txt_f="3633">Sandström et al. 2003</offsets></xref><offsets xml_i="10142" xml_f="10144" txt_i="3633" txt_f="3635">).</offsets></p><p><offsets xml_i="10151" xml_f="10462" txt_i="3636" txt_f="3947">To address the question of whether TETRA communication technology has any impact on health and well-being, the U.K. Home Office has funded a large-scale epidemiological study to assess whether Airwave handsets have an impact on the health of police officers, and the results of this study are expected in 2018 (</offsets><xref rid="b2-ehp-118-735" ref-type="bibr"><offsets xml_i="10505" xml_f="10541" txt_i="3947" txt_f="3983">Airwave Health Monitoring Study 2009</offsets></xref><offsets xml_i="10548" xml_f="11219" txt_i="3983" txt_f="4654">). In addition, the present randomized double-blind study was funded to assess the short-term impact of TETRA signals on indices of health and well-being in both self-reported electrosensitive individuals and members of the general public who do not report problems with mobile phone technologies. Little scientific information is currently available on the possible impact of TETRA on health. Randomized double-blind studies on Global System for Mobile Communication (GSM) and Universal Mobile Telecommunications System (UMTS) have reported no reproducible evidence of adverse health effects for either healthy controls or individuals with perceived electrosensitivity (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="11262" xml_f="11281" txt_i="4654" txt_f="4673">Eltiti et al. 2007a</offsets></xref><offsets xml_i="11288" xml_f="11290" txt_i="4673" txt_f="4675">; </offsets><xref rid="b23-ehp-118-735" ref-type="bibr"><offsets xml_i="11334" xml_f="11351" txt_i="4675" txt_f="4692">Regel et al. 2006</offsets></xref><offsets xml_i="11358" xml_f="11360" txt_i="4692" txt_f="4694">; </offsets><xref rid="b25-ehp-118-735" ref-type="bibr"><offsets xml_i="11404" xml_f="11421" txt_i="4694" txt_f="4711">Rubin et al. 2006</offsets></xref><offsets xml_i="11428" xml_f="11552" txt_i="4711" txt_f="4835">). Moreover, neither electrosensitive nor healthy individuals can detect the presence of EMFs at rates greater than chance (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="11595" xml_f="11614" txt_i="4835" txt_f="4854">Eltiti et al. 2007a</offsets></xref><offsets xml_i="11621" xml_f="11623" txt_i="4854" txt_f="4856">; </offsets><xref rid="b15-ehp-118-735" ref-type="bibr"><offsets xml_i="11667" xml_f="11683" txt_i="4856" txt_f="4872">Kwon et al. 2008</offsets></xref><offsets xml_i="11690" xml_f="11692" txt_i="4872" txt_f="4874">; </offsets><xref rid="b23-ehp-118-735" ref-type="bibr"><offsets xml_i="11736" xml_f="11753" txt_i="4874" txt_f="4891">Regel et al. 2006</offsets></xref><offsets xml_i="11760" xml_f="11762" txt_i="4891" txt_f="4893">; </offsets><xref rid="b25-ehp-118-735" ref-type="bibr"><offsets xml_i="11806" xml_f="11823" txt_i="4893" txt_f="4910">Rubin et al. 2006</offsets></xref><offsets xml_i="11830" xml_f="11832" txt_i="4910" txt_f="4912">, </offsets><xref rid="b26-ehp-118-735" ref-type="bibr"><offsets xml_i="11876" xml_f="11880" txt_i="4912" txt_f="4916">2010</offsets></xref><offsets xml_i="11887" xml_f="11889" txt_i="4916" txt_f="4918">; </offsets><xref rid="b30-ehp-118-735" ref-type="bibr"><offsets xml_i="11933" xml_f="11953" txt_i="4918" txt_f="4938">Zwamborn et al. 2003</offsets></xref><offsets xml_i="11960" xml_f="12025" txt_i="4938" txt_f="5003">). In a recent study using functional magnetic resonance imaging </offsets><xref rid="b16-ehp-118-735" ref-type="bibr"><offsets xml_i="12069" xml_f="12092" txt_i="5003" txt_f="5026">Landgrebe et al. (2008)</offsets></xref><offsets xml_i="12099" xml_f="12575" txt_i="5026" txt_f="5502"> showed that the subjective perception of symptoms was triggered by the anticipation of being exposed to an EMF. This finding led to the implication that these symptoms are due to beliefs and anticipation of harm rather than to the EMFs themselves. Consequently, the World Health Organization has suggested that terms such as “electrosensitivity” should be replaced by IEI-EMF to acknowledge the absence of evidence for a causal connection between EMFs and reported symptoms (</offsets><xref rid="b12-ehp-118-735" ref-type="bibr"><offsets xml_i="12619" xml_f="12643" txt_i="5502" txt_f="5526">Hansson Mild et al. 2006</offsets></xref><offsets xml_i="12650" xml_f="12652" txt_i="5526" txt_f="5528">).</offsets></p><p><offsets xml_i="12659" xml_f="12834" txt_i="5529" txt_f="5704">The health concerns regarding TETRA handsets and base stations are predominantly focused on the 17.6-Hz pulse frequency feature and its possible impact on biological systems [</offsets><xref rid="b1-ehp-118-735" ref-type="bibr"><offsets xml_i="12877" xml_f="12930" txt_i="5704" txt_f="5757">Advisory Group on Non-Ionising Radiation (AGNIR) 2001</offsets></xref><offsets xml_i="12937" xml_f="13273" txt_i="5757" txt_f="6093">]. In 2001, the AGNIR reviewed all of the available evidence, including calcium efflux, brain waves, and epilepsy. The group concluded that any effect on biological systems would require a nonlinear biological interaction that operated on the time scale of the carrier frequency that could demodulate the amplitude-modulated component (</offsets><xref rid="b7-ehp-118-735" ref-type="bibr"><offsets xml_i="13316" xml_f="13328" txt_i="6093" txt_f="6105">Challis 2005</offsets></xref><offsets xml_i="13335" xml_f="13337" txt_i="6105" txt_f="6107">; </offsets><xref rid="b21-ehp-118-735" ref-type="bibr"><offsets xml_i="13381" xml_f="13390" txt_i="6107" txt_f="6116">NRPB 2001</offsets></xref><offsets xml_i="13397" xml_f="13399" txt_i="6116" txt_f="6118">; </offsets><xref rid="b28-ehp-118-735" ref-type="bibr"><offsets xml_i="13443" xml_f="13462" txt_i="6118" txt_f="6137">Valberg et al. 2007</offsets></xref><offsets xml_i="13469" xml_f="13638" txt_i="6137" txt_f="6306">). Given this, the AGNIR concluded that TETRA was highly unlikely to pose a health risk but nevertheless recommended that well-designed laboratory studies be conducted (</offsets><xref rid="b21-ehp-118-735" ref-type="bibr"><offsets xml_i="13682" xml_f="13691" txt_i="6306" txt_f="6315">NRPB 2001</offsets></xref><offsets xml_i="13698" xml_f="13806" txt_i="6315" txt_f="6423">). Only two studies investigating TETRA technology have been published since the AGNIR report was released. </offsets><xref rid="b11-ehp-118-735" ref-type="bibr"><offsets xml_i="13850" xml_f="13869" txt_i="6423" txt_f="6442">Green et al. (2005)</offsets></xref><offsets xml_i="13876" xml_f="14023" txt_i="6442" txt_f="6589"> found no evidence that TETRA handsets produced significant changes in calcium physiology in the brain as a consequence of TETRA exposure, whereas </offsets><xref rid="b3-ehp-118-735" ref-type="bibr"><offsets xml_i="14066" xml_f="14086" txt_i="6589" txt_f="6609">Barker et al. (2007)</offsets></xref><offsets xml_i="14093" xml_f="14302" txt_i="6609" txt_f="6818"> reported that neither GSM nor TETRA handset signals affected blood pressure or any other physiological parameter. The present study is the first report of the short-term health effects of TETRA base stations.</offsets></p><p><offsets xml_i="14309" xml_f="14941" txt_i="6819" txt_f="7451">The aims of the present study were to determine whether symptoms reported by IEI-EMF sufferers are caused by short-term exposure to radiofrequency (RF) EMFs as produced by TETRA base station signals and to determine whether exposure to these signals affects a selection of the adult population that do not report sensitivity to EMFs. We tested TETRA base station signals on both healthy controls and IEI-EMF sufferers under open provocation and double-blind conditions while measuring a range of objective and subjective indicators of well-being, as well as the participants’ ability to detect the presence or absence of the signal.</offsets></p><sec sec-type="materials|methods"><title><offsets xml_i="14986" xml_f="15007" txt_i="7452" txt_f="7473">Materials and Methods</offsets></title><sec sec-type="subjects"><title><offsets xml_i="15047" xml_f="15059" txt_i="7474" txt_f="7486">Participants</offsets></title><p><offsets xml_i="15070" xml_f="15155" txt_i="7487" txt_f="7572">All participants completed the Electromagnetic Hypersensitivity Questionnaire (EHQ) (</offsets><xref rid="b9-ehp-118-735" ref-type="bibr"><offsets xml_i="15198" xml_f="15217" txt_i="7572" txt_f="7591">Eltiti et al. 2007b</offsets></xref><offsets xml_i="15224" xml_f="16729" txt_i="7591" txt_f="9096">) prior to testing, which provided an assessment of their current state of health and whether participants attributed their symptoms to EMFs. Volunteers in the sensitive group were selected on the basis of a self-report of being sensitive to EMFs, particularly those produced by mobile communication handsets and base stations. Volunteers in the control group confirmed that they were not sensitive to EMFs. Volunteers were excluded if they fulfilled one or more of the following criteria: were outside the age range of 18–80 years, had a history of brain injury, had a diagnosis of epilepsy or claustrophobia, had received a diagnosis or any treatment for a mental disease, had been fitted with a pacemaker, or had any physical impairment or illness or were taking any medication that could have, in some way, affected the results of the study. Particpants were recruited through local and national newspaper advertisements, letters of invitation, specialist health publications, personal recommendation, and Web site contact; they were reimbursed their travel expenses and received a small payment. All testing took place at a specialized Electromagnetics and Health Laboratory at the University of Essex (Colchester, UK) and was approved by the University of Essex Ethics Committee, the National Research Ethics Service, and the East of England Ambulance Service internal ethics group. All participants gave written informed consent before testing, which took place between April 2007 and January 2009.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="16770" xml_f="16776" txt_i="9098" txt_f="9104">Design</offsets></title><p><offsets xml_i="16787" xml_f="17254" txt_i="9105" txt_f="9572">A mixed design was used in which two groups (between subjects: sensitive and controls) were exposed to two exposure conditions (within subjects: TETRA and sham). Each participant took part in an open provocation session and two double-blind sessions. Each session was spaced at least 1 week apart and was conducted at about the same time of day. Subjective well-being and physiological functioning were measured during each session throughout the exposure conditions.</offsets></p><p><offsets xml_i="17261" xml_f="17940" txt_i="9573" txt_f="10252">The initial open provocation session consisted of two tests where both the experimenter and the participant knew when the base station was “on” and when it was “off.” This was followed by a brief double-blind test comprising four short-duration trials with two on and two off conditions. Sessions 2 and 3 comprised the double-blind component of the study, with just one exposure (TETRA or sham) being administered during each of these sessions. All participants received both exposure conditions counterbalanced across sessions 2 and 3. Exposure conditions were block-randomized within group and preprogrammed into the exposure system control computer by an external consultant (</offsets><xref rid="b4-ehp-118-735" ref-type="bibr"><offsets xml_i="17983" xml_f="17995" txt_i="10252" txt_f="10264">Belloul 2008</offsets></xref><offsets xml_i="18002" xml_f="18085" txt_i="10264" txt_f="10347">). Double-blinding remained in place until completion of the data collection phase.</offsets></p><p><offsets xml_i="18092" xml_f="18190" txt_i="10348" txt_f="10446">Our sample size was calculated on the assumption that RF-EMFs has a small effect on human health (</offsets><italic><offsets xml_i="18198" xml_f="18199" txt_i="10446" txt_f="10447">d</offsets></italic><offsets xml_i="18208" xml_f="18570" txt_i="10447" txt_f="10809"> = 0.40). Hence, 66 participants per group would yield statistical power of 0.90 for within-subjects effects, which allowed us to be 90% confident about differences found between sham and TETRA exposure conditions. The same level of confidence for between-subjects effects (i.e., group by exposure condition interaction) would require 132 participants per group.</offsets></p></sec><sec sec-type="materials"><title><offsets xml_i="18613" xml_f="18667" txt_i="10811" txt_f="10865">Materials and equipment: screened semianechoic chamber</offsets></title><p><offsets xml_i="18678" xml_f="19447" txt_i="10866" txt_f="11635">The testing room had a shielding effectiveness between 55 and 60 dB at 420 MHz. The appropriate depth absorber (300 mm) was used to achieve a uniform field at 420 MHz and conformed to the BS EN 61000-4-3:2006 “on” + A1: 2008 specification (National Physical Laboratory, Teddington, Middlesex, UK). Participants were seated 4.95 m from the antenna of the base station. A screen was placed 2.8 m from the participant, blocking the antenna from view, and was used to back-project task instructions for the participant during testing. The projector was positioned outside the testing room at the back wall, and projection was made through a screened window behind the antenna. A screened window in the near wall allowed visual contact between experimenter and participant (</offsets><xref ref-type="fig" rid="f1-ehp-118-735"><offsets xml_i="19489" xml_f="19497" txt_i="11635" txt_f="11643">Figure 1</offsets></xref><offsets xml_i="19504" xml_f="19506" txt_i="11643" txt_f="11645">).</offsets></p><sec><title><offsets xml_i="19522" xml_f="19537" txt_i="11646" txt_f="11661">Exposure system</offsets></title><p><offsets xml_i="19548" xml_f="19929" txt_i="11662" txt_f="12043">We used the TETRA signal release 1 [specification 390 392–2; European Telecommunications Standards Institute (ETSI), Sophia-Antipolis Cedex, France], which comprised a time-division multiple-access frame structure with four time slots per frame on a single carrier. The chosen frequency was 420 MHz with a 25-kHz bandwidth. The signal was emitted at a power flux density of 10 mW/m</offsets><sup><offsets xml_i="19934" xml_f="19935" txt_i="12043" txt_f="12044">2</offsets></sup><offsets xml_i="19941" xml_f="20790" txt_i="12044" txt_f="12893"> (uncertainty estimate, 1 dB) over the area in which the participant was seated. Calculating a value for the Specific Absorption Rate (SAR) for whole body exposure is extremely complex; the variation in both the electrical properties of individual tissues and their spatial distributions means that SAR will never be uniform across the tissues of the body. In addition, SAR calculations should ideally be based on measurements using either a physical or numerical phantom, neither of which was available to us. Nevertheless, we would like to provide an estimated SAR for the present study. We calculated an approximate corresponding SAR for the power level used with this formula: body surface area × power flux density ÷ body weight. We used assumed values for body surface area and body weight; thus, for a person with a body surface area of 1.9 m</offsets><sup><offsets xml_i="20795" xml_f="20796" txt_i="12893" txt_f="12894">2</offsets></sup><offsets xml_i="20802" xml_f="21047" txt_i="12894" txt_f="13139"> and a body weight of 70 kg, the approximate corresponding SAR for this power level is 271 μW/kg (1.9 × 10mW/70 kg). The maximum power produced by TETRA base station transmitters is comparable to those of mobile phone base station transmitters (</offsets><xref rid="b21-ehp-118-735" ref-type="bibr"><offsets xml_i="21091" xml_f="21100" txt_i="13139" txt_f="13148">NRPB 2001</offsets></xref><offsets xml_i="21107" xml_f="21226" txt_i="13148" txt_f="13267">). In the absence of any other available evidence, we broadly based the power level for this study on one conducted by </offsets><xref rid="b19-ehp-118-735" ref-type="bibr"><offsets xml_i="21270" xml_f="21288" txt_i="13267" txt_f="13285">Mann et al. (2000)</offsets></xref><offsets xml_i="21295" xml_f="21405" txt_i="13285" txt_f="13395"> who measured signal strengths of mobile phone base stations around the United Kingdom. With reference to the </offsets><xref rid="b13-ehp-118-735" ref-type="bibr"><offsets xml_i="21449" xml_f="21517" txt_i="13395" txt_f="13463">International Commission on Non-Ionizing Radiation Protection (1998)</offsets></xref><offsets xml_i="21524" xml_f="21599" txt_i="13463" txt_f="13538"> guidelines the power level used in the present study is 0.5% of the 2.1W/m</offsets><sup><offsets xml_i="21604" xml_f="21605" txt_i="13538" txt_f="13539">2</offsets></sup><offsets xml_i="21611" xml_f="22210" txt_i="13539" txt_f="14138"> reference level for the general public. The properties of the TETRA signal were modeled directly on the TETRA system that is currently used by the emergency services, thus replicating as closely as possible actual base-station emissions. Whether or not traffic is carried on the channel has a profound effect on the waveform. Thus, to allow for the harmonics of the time slots, a ratio of time slot occupancy of 50% traffic/no traffic was applied over the period of the tests. The sham condition comprised a no-signal condition. [A copy of the technical reference manual is available upon request (</offsets><xref rid="b4-ehp-118-735" ref-type="bibr"><offsets xml_i="22253" xml_f="22265" txt_i="14138" txt_f="14150">Belloul 2008</offsets></xref><offsets xml_i="22272" xml_f="22275" txt_i="14150" txt_f="14153">).]</offsets></p><p><offsets xml_i="22282" xml_f="22506" txt_i="14154" txt_f="14378">Regular calibrations confirmed that power density levels remained within 1 dB variability tolerance throughout the study period. The field uniformity was independently tested and verified by the National Physical Laboratory.</offsets></p></sec><sec><title><offsets xml_i="22528" xml_f="22552" txt_i="14380" txt_f="14404">Biographical information</offsets></title><p><offsets xml_i="22563" xml_f="22717" txt_i="14405" txt_f="14559">Participation began with a medical history interview, which provided biographical information and assessed participants’ state of health prior to testing.</offsets></p></sec><sec><title><offsets xml_i="22739" xml_f="22760" txt_i="14561" txt_f="14582">Subjective well-being</offsets></title><p><offsets xml_i="22771" xml_f="23275" txt_i="14583" txt_f="15087">Visual analog scales (VASs) and symptom scales were used to measure subjective well-being. The VAS each comprised a 10-cm line, with 0 cm representing “not at all” and 10 cm “extremely,” for anxiety, tension, arousal, relaxation, discomfort, and fatigue. The corresponding descriptors were “anxious,” “tense,” “agitated,” “relaxed,” “discomfort,” and “tired.” Participants were asked to mark anywhere on the line corresponding to how they felt at that time. The symptom scales were derived from the EHQ (</offsets><xref rid="b9-ehp-118-735" ref-type="bibr"><offsets xml_i="23318" xml_f="23337" txt_i="15087" txt_f="15106">Eltiti et al. 2007b</offsets></xref><offsets xml_i="23344" xml_f="23509" txt_i="15106" txt_f="15271">) and comprised 57 symptoms on a 5-point scale (“not at all” to “a great deal”); participants were required to select how much they were suffering from each symptom.</offsets></p></sec><sec><title><offsets xml_i="23531" xml_f="23553" txt_i="15273" txt_f="15295">Physiological measures</offsets></title><p><offsets xml_i="23564" xml_f="24700" txt_i="15296" txt_f="16432">Physiological effects were measured using the means ± SDs for blood volume pulse (BVP), heart rate (HR), and skin conductance (SC) recorded throughout the open provocation and double- blind tests. We recorded physiological data using a ProComp Infiniti eight-channel encoder with Biograph Infiniti software [version 2.0.1; Thought Technology Ltd., Plattsburgh, New York, USA (2003)] that we ran on a Dell Latitude notebook (Dell Products UK, Dublin, Ireland). Signals were sampled at a rate of 2,048 samples/sec for BVP and 256 samples/sec for SC. The BVP was submitted to a fourth-order Butterworth low-pass filter with a 10-Hz cutoff frequency. The HR was calculated from the filtered BVP by calculating the time locations for the BVP peaks and valleys based on the locations on which the derivative of the BVP reached zero (dicrotic notches were ignored by the algorithm). HR was then estimated based on the time between peaks: HR = 1/(interpeak interval). All signals were resampled at 8 samples/sec to have a uniform rate. BVP signals were detrended because the important information in this signal was on the peak-to-peak values (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="24743" xml_f="24762" txt_i="16432" txt_f="16451">Eltiti et al. 2007a</offsets></xref><offsets xml_i="24769" xml_f="24771" txt_i="16451" txt_f="16453">).</offsets></p></sec><sec><title><offsets xml_i="24793" xml_f="24813" txt_i="16455" txt_f="16475">“On”/“Off” judgments</offsets></title><p><offsets xml_i="24824" xml_f="25127" txt_i="16476" txt_f="16779">There were six double-blind on/off judgments: four 5-min trials after the open provocation component and two 50-min trials. Participants were required to judge whether the base station was “on” or “off” and to indicate whether their confidence was “low,” “moderate,” or “high” directly after each trial.</offsets></p></sec><sec><title><offsets xml_i="25149" xml_f="25158" txt_i="16781" txt_f="16790">Procedure</offsets></title><p><offsets xml_i="25169" xml_f="25402" txt_i="16791" txt_f="17024">The open provocation test and the 5-min double-blind tests were conducted in session 1. Sessions 2 and 3 were double-blind and contained one exposure condition each. Ordering of exposure condition was randomized across participants. </offsets><xref ref-type="table" rid="t1-ehp-118-735"><offsets xml_i="25446" xml_f="25453" txt_i="17024" txt_f="17031">Table 1</offsets></xref><offsets xml_i="25460" xml_f="25492" txt_i="17031" txt_f="17063"> shows the procedures in detail.</offsets></p></sec></sec><sec><title><offsets xml_i="25520" xml_f="25540" txt_i="17066" txt_f="17086">Statistical analyses</offsets></title><p><offsets xml_i="25551" xml_f="25859" txt_i="17087" txt_f="17395">We adjusted the alpha levels using the Bonferroni correction to control for type 1 error. Analysis of variance (ANOVA) was used to measure mean differences of data with normal distributions. Where the distributions were skewed and could not be normalized, we used nonparametric methods instead; Mann–Whitney </offsets><italic><offsets xml_i="25867" xml_f="25868" txt_i="17395" txt_f="17396">U</offsets></italic><offsets xml_i="25877" xml_f="26195" txt_i="17396" txt_f="17714">-tests were used for between-group comparisons, and Wilcoxon signed rank tests for within-group comparisons. Nonparametric tests lack the flexibility of ANOVAs, which calculate interaction effects. To mimic this type of analysis using nonparametric methods, we performed between-subjects analyses on difference scores.</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="26242" xml_f="26249" txt_i="17717" txt_f="17724">Results</offsets></title><sec><title><offsets xml_i="26269" xml_f="26293" txt_i="17725" txt_f="17749">Biographical information</offsets></title><p><offsets xml_i="26304" xml_f="26398" txt_i="17750" txt_f="17844">Fifty-one “sensitive” participants and 144 control volunteers completed at least one session (</offsets><xref ref-type="fig" rid="f2-ehp-118-735"><offsets xml_i="26440" xml_f="26448" txt_i="17844" txt_f="17852">Figure 2</offsets></xref><offsets xml_i="26455" xml_f="26854" txt_i="17852" txt_f="18251">). However, during the testing, we lost data for five controls because of technical failures, and one person withdrew after session 1. Additionally, we tested controls more quickly than sensitives and found that the ratio of males to females was significantly higher for the controls compared with the sensitive group. Therefore, we tested an additional six females and randomly replaced six males (</offsets><xref ref-type="fig" rid="f2-ehp-118-735"><offsets xml_i="26896" xml_f="26904" txt_i="18251" txt_f="18259">Figure 2</offsets></xref><offsets xml_i="26911" xml_f="27073" txt_i="18259" txt_f="18421">). Our final sample of 183 (51 sensitives, 132 controls) included 10 emergency service workers, of these, two were sensitive participants. An independent-samples </offsets><italic><offsets xml_i="27081" xml_f="27082" txt_i="18421" txt_f="18422">t</offsets></italic><offsets xml_i="27091" xml_f="27242" txt_i="18422" txt_f="18573">-test showed that the sensitive groups (mean ± SD = 42 ± 16; range, 18–73) and control groups (41 ± 19; range, 18–80) were comparable in terms of age [</offsets><italic><offsets xml_i="27250" xml_f="27251" txt_i="18573" txt_f="18574">t</offsets></italic><offsets xml_i="27260" xml_f="27275" txt_i="18574" txt_f="18589">(181) = 0.289, </offsets><italic><offsets xml_i="27283" xml_f="27284" txt_i="18589" txt_f="18590">p</offsets></italic><offsets xml_i="27293" xml_f="27361" txt_i="18590" txt_f="18655"> &gt; 0.77] and sex [sensitives, 61% female; controls, 51% female; χ</offsets><sup><offsets xml_i="27366" xml_f="27367" txt_i="18655" txt_f="18656">2</offsets></sup><offsets xml_i="27373" xml_f="27387" txt_i="18656" txt_f="18670"> (1) = 1.487, </offsets><italic><offsets xml_i="27395" xml_f="27396" txt_i="18670" txt_f="18671">p</offsets></italic><offsets xml_i="27405" xml_f="27416" txt_i="18671" txt_f="18679"> &gt; 0.2].</offsets></p><p><offsets xml_i="27423" xml_f="28319" txt_i="18680" txt_f="19576">The EHQ responses indicated that 11 (21.6%) sensitive participants reported being “a little bit” sensitive, 10 (19.6%) “moderately,” 11 (21.6%) “quite a bit,” and 12 (23.5%) “a great deal.” Six (11.8%) reported that they were not sensitive to EMFs but specified EMF-emitting objects as being associated with their symptoms. We conducted telephone interviews with these participants to establish eligibility to participate as sensitive before attending session 1. One person in the sensitive sample did not complete the EHQ before participating but was invited after a telephone interview. Assuming that any differences between these subgroups would be greatest under open provocation conditions, we performed Kruskal–Wallis tests on the open provocation physiological measures, VASs, and symptom scales. The outcomes for all these comparisons suggest that these groups were broadly comparable [(χ</offsets><sup><offsets xml_i="28324" xml_f="28325" txt_i="19576" txt_f="19577">2</offsets></sup><offsets xml_i="28331" xml_f="28345" txt_i="19577" txt_f="19591"> (4) ≤ 5.659, </offsets><italic><offsets xml_i="28353" xml_f="28354" txt_i="19591" txt_f="19592">p</offsets></italic><offsets xml_i="28363" xml_f="28375" txt_i="19592" txt_f="19601"> &gt; 0.28].</offsets></p><p><offsets xml_i="28382" xml_f="28522" txt_i="19602" txt_f="19742">Some participants had comorbid chronic conditions. The most commonly reported condition in both groups was high blood pressure (sensitives, </offsets><italic><offsets xml_i="28530" xml_f="28531" txt_i="19742" txt_f="19743">n</offsets></italic><offsets xml_i="28540" xml_f="28556" txt_i="19743" txt_f="19759"> = 2; controls, </offsets><italic><offsets xml_i="28564" xml_f="28565" txt_i="19759" txt_f="19760">n</offsets></italic><offsets xml_i="28574" xml_f="28619" txt_i="19760" txt_f="19805"> = 4); asthma was also reported (sensitives, </offsets><italic><offsets xml_i="28627" xml_f="28628" txt_i="19805" txt_f="19806">n</offsets></italic><offsets xml_i="28637" xml_f="28653" txt_i="19806" txt_f="19822"> = 1; controls, </offsets><italic><offsets xml_i="28661" xml_f="28662" txt_i="19822" txt_f="19823">n</offsets></italic><offsets xml_i="28671" xml_f="28916" txt_i="19823" txt_f="20068"> = 1). One person in the sensitive group reported being “hypoglycemic,” and another reported suffering from both myalgic encephalomyelitis and irritable bowel syndrome. In the control group, chronic conditions reported were underactive thyroid (</offsets><italic><offsets xml_i="28924" xml_f="28925" txt_i="20068" txt_f="20069">n</offsets></italic><offsets xml_i="28934" xml_f="28958" txt_i="20069" txt_f="20093"> = 3), type 2 diabetes (</offsets><italic><offsets xml_i="28966" xml_f="28967" txt_i="20093" txt_f="20094">n</offsets></italic><offsets xml_i="28976" xml_f="29000" txt_i="20094" txt_f="20118"> = 2), type 1 diabetes (</offsets><italic><offsets xml_i="29008" xml_f="29009" txt_i="20118" txt_f="20119">n</offsets></italic><offsets xml_i="29018" xml_f="29036" txt_i="20119" txt_f="20137"> = 1), arthritis (</offsets><italic><offsets xml_i="29044" xml_f="29045" txt_i="20137" txt_f="20138">n</offsets></italic><offsets xml_i="29054" xml_f="29073" txt_i="20138" txt_f="20157"> = 1), bronchitis (</offsets><italic><offsets xml_i="29081" xml_f="29082" txt_i="20157" txt_f="20158">n</offsets></italic><offsets xml_i="29091" xml_f="29117" txt_i="20158" txt_f="20184"> = 1), prostate problems (</offsets><italic><offsets xml_i="29125" xml_f="29126" txt_i="20184" txt_f="20185">n</offsets></italic><offsets xml_i="29135" xml_f="29155" txt_i="20185" txt_f="20205"> = 1), back injury (</offsets><italic><offsets xml_i="29163" xml_f="29164" txt_i="20205" txt_f="20206">n</offsets></italic><offsets xml_i="29173" xml_f="29188" txt_i="20206" txt_f="20221"> = 1), hernia (</offsets><italic><offsets xml_i="29196" xml_f="29197" txt_i="20221" txt_f="20222">n</offsets></italic><offsets xml_i="29206" xml_f="29231" txt_i="20222" txt_f="20247"> = 1), and osteoporosis (</offsets><italic><offsets xml_i="29239" xml_f="29240" txt_i="20247" txt_f="20248">n</offsets></italic><offsets xml_i="29249" xml_f="29326" txt_i="20248" txt_f="20325"> = 1). In addition, one participant reported being prone to gastroenteritis. </offsets><xref ref-type="table" rid="t2-ehp-118-735"><offsets xml_i="29370" xml_f="29377" txt_i="20325" txt_f="20332">Table 2</offsets></xref><offsets xml_i="29384" xml_f="29561" txt_i="20332" txt_f="20509"> presents health comparisons between sensitive and control participants. Chi-square tests indicated a significant difference between the groups only for “headache proneness” [(χ</offsets><sup><offsets xml_i="29566" xml_f="29567" txt_i="20509" txt_f="20510">2</offsets></sup><offsets xml_i="29573" xml_f="29588" txt_i="20510" txt_f="20525"> (1) = 12.736, </offsets><italic><offsets xml_i="29596" xml_f="29597" txt_i="20525" txt_f="20526">p</offsets></italic><offsets xml_i="29606" xml_f="29705" txt_i="20526" txt_f="20622"> &lt; 0.001], with a greater percentage of sensitives reporting “headache proneness” than controls.</offsets></p></sec><sec><title><offsets xml_i="29727" xml_f="29747" txt_i="20624" txt_f="20644">Visual analog scales</offsets></title><p><offsets xml_i="29758" xml_f="30114" txt_i="20645" txt_f="21001">We analyzed all VAS data using nonparametric statistics. We took baseline VAS measures before each test. However, this meant that for the open provocation test there was one baseline measure for both exposure conditions. We therefore included baseline scores only for the double-blind analyses, where one baseline measure served for one exposure condition.</offsets></p><p><offsets xml_i="30121" xml_f="30239" txt_i="21002" txt_f="21120">In the open provocation test, we found an overall difference for group (sensitive vs. control) for all six variables (</offsets><italic><offsets xml_i="30247" xml_f="30248" txt_i="21120" txt_f="21121">p</offsets></italic><offsets xml_i="30257" xml_f="30525" txt_i="21121" txt_f="21389"> ≤ 0.008), indicating that sensitives experienced greater anxiety, tension, arousal, discomfort, and fatigue and less relaxation than controls, regardless of exposure condition. The overall difference for exposure (TETRA, sham) was also significant for all variables (</offsets><italic><offsets xml_i="30533" xml_f="30534" txt_i="21389" txt_f="21390">p</offsets></italic><offsets xml_i="30543" xml_f="30576" txt_i="21390" txt_f="21420"> &lt; 0.001) except for fatigue (</offsets><italic><offsets xml_i="30584" xml_f="30585" txt_i="21420" txt_f="21421">p</offsets></italic><offsets xml_i="30594" xml_f="30712" txt_i="21421" txt_f="21539"> = 0.037, α = 0.008), indicating that participants, independent of group, felt worse during TETRA compared with sham. </offsets><xref ref-type="table" rid="t3-ehp-118-735"><offsets xml_i="30756" xml_f="30763" txt_i="21539" txt_f="21546">Table 3</offsets></xref><offsets xml_i="30770" xml_f="31281" txt_i="21546" txt_f="22057"> shows that, under TETRA conditions compared with sham, controls reported significantly higher levels of anxiety only. However, sensitive participants reported higher levels of anxiety, tension, arousal, and discomfort and lower levels of relaxation during TETRA compared with sham. Analyses of difference scores (TETRA – sham) revealed that sensitive participants reported a significantly greater increase in levels of anxiety, tension, arousal, and discomfort during the TETRA exposure compared with controls.</offsets></p><p><offsets xml_i="31288" xml_f="31378" txt_i="22058" txt_f="22148">Under double-blind conditions, we found no significant overall difference between groups (</offsets><italic><offsets xml_i="31386" xml_f="31387" txt_i="22148" txt_f="22149">p</offsets></italic><offsets xml_i="31396" xml_f="31470" txt_i="22149" txt_f="22223"> ≥ 0.1). For exposure condition, relaxation alone emerged as significant (</offsets><italic><offsets xml_i="31478" xml_f="31479" txt_i="22223" txt_f="22224">z</offsets></italic><offsets xml_i="31488" xml_f="31499" txt_i="22224" txt_f="22235"> = −2.713, </offsets><italic><offsets xml_i="31507" xml_f="31508" txt_i="22235" txt_f="22236">p</offsets></italic><offsets xml_i="31517" xml_f="31638" txt_i="22236" txt_f="22357"> = 0.007), with higher relaxation being reported during TETRA (mean ± SE, 6.76 ± 0.12) compared with sham (6.54 ± 0.11). </offsets><xref ref-type="table" rid="t4-ehp-118-735"><offsets xml_i="31682" xml_f="31689" txt_i="22357" txt_f="22364">Table 4</offsets></xref></p></sec><sec><title><offsets xml_i="31718" xml_f="31732" txt_i="22366" txt_f="22380">Symptom scales</offsets></title><p><offsets xml_i="31743" xml_f="31893" txt_i="22381" txt_f="22531">We also analyzed total symptom score, which measures symptom severity, and the total number of symptoms reported by means of nonparametric statistics.</offsets></p><p><offsets xml_i="31900" xml_f="32014" txt_i="22532" txt_f="22646">During the open provocation test, we found an overall difference between groups for both the total symptom score (</offsets><italic><offsets xml_i="32022" xml_f="32023" txt_i="22646" txt_f="22647">z</offsets></italic><offsets xml_i="32032" xml_f="32043" txt_i="22647" txt_f="22658"> = −5.985, </offsets><italic><offsets xml_i="32051" xml_f="32052" txt_i="22658" txt_f="22659">p</offsets></italic><offsets xml_i="32061" xml_f="32113" txt_i="22659" txt_f="22708"> &lt; 0.001) and total number of symptoms reported (</offsets><italic><offsets xml_i="32121" xml_f="32122" txt_i="22708" txt_f="22709">z</offsets></italic><offsets xml_i="32131" xml_f="32142" txt_i="22709" txt_f="22720"> = −6.448, </offsets><italic><offsets xml_i="32150" xml_f="32151" txt_i="22720" txt_f="22721">p</offsets></italic><offsets xml_i="32160" xml_f="32270" txt_i="22721" txt_f="22828"> &lt; 0.001), indicating that sensitive participants experienced a greater severity (mean ± SE = 5.92 ± 1.23, </offsets><italic><offsets xml_i="32278" xml_f="32279" txt_i="22828" txt_f="22829">n</offsets></italic><offsets xml_i="32288" xml_f="32332" txt_i="22829" txt_f="22873"> = 51) and number of symptoms (4.63 ± 0.86, </offsets><italic><offsets xml_i="32340" xml_f="32341" txt_i="22873" txt_f="22874">n</offsets></italic><offsets xml_i="32350" xml_f="32419" txt_i="22874" txt_f="22943"> = 51) than did controls (1.04 ± 0.17 and 0.92 ± 0.13, respectively; </offsets><italic><offsets xml_i="32427" xml_f="32428" txt_i="22943" txt_f="22944">n</offsets></italic><offsets xml_i="32437" xml_f="32546" txt_i="22944" txt_f="23053"> = 132). We also found an overall difference for exposure condition (TETRA, sham) for symptom severity only (</offsets><italic><offsets xml_i="32554" xml_f="32555" txt_i="23053" txt_f="23054">z</offsets></italic><offsets xml_i="32564" xml_f="32575" txt_i="23054" txt_f="23065"> = −2.255, </offsets><italic><offsets xml_i="32583" xml_f="32584" txt_i="23065" txt_f="23066">p</offsets></italic><offsets xml_i="32593" xml_f="32832" txt_i="23066" txt_f="23305"> = 0.024), suggesting that all participants experienced greater symptom severity when exposed to TETRA (2.89 ± 0.552) compared with sham (1.91 ± 0.322). The total number of symptoms reported remained comparable across exposure conditions (</offsets><italic><offsets xml_i="32840" xml_f="32841" txt_i="23305" txt_f="23306">z</offsets></italic><offsets xml_i="32850" xml_f="32861" txt_i="23306" txt_f="23317"> = −1.874, </offsets><italic><offsets xml_i="32869" xml_f="32870" txt_i="23317" txt_f="23318">p</offsets></italic><offsets xml_i="32879" xml_f="33031" txt_i="23318" txt_f="23467"> &gt; 0.06). Control participants reported no differences between exposure conditions for either symptom severity or total number of symptoms reported (</offsets><xref ref-type="table" rid="t5-ehp-118-735"><offsets xml_i="33075" xml_f="33082" txt_i="23467" txt_f="23474">Table 5</offsets></xref><offsets xml_i="33089" xml_f="33398" txt_i="23474" txt_f="23783">). In contrast, the sensitive participants reported a significantly higher total symptom score and more symptoms during TETRA than during sham. The between-group analyses of difference scores (TETRA – sham) revealed a significant difference for both total symptom score and total number of symptoms reported (</offsets><xref ref-type="table" rid="t5-ehp-118-735"><offsets xml_i="33442" xml_f="33449" txt_i="23783" txt_f="23790">Table 5</offsets></xref><offsets xml_i="33456" xml_f="33458" txt_i="23790" txt_f="23792">).</offsets></p><p><offsets xml_i="33465" xml_f="33574" txt_i="23793" txt_f="23902">Under double-blind conditions, we found a significant difference between groups for the total symptom score (</offsets><italic><offsets xml_i="33582" xml_f="33583" txt_i="23902" txt_f="23903">z</offsets></italic><offsets xml_i="33592" xml_f="33603" txt_i="23903" txt_f="23914"> = −4.917, </offsets><italic><offsets xml_i="33611" xml_f="33612" txt_i="23914" txt_f="23915">p</offsets></italic><offsets xml_i="33621" xml_f="33673" txt_i="23915" txt_f="23964"> &lt; 0.001) and total number of symptoms reported (</offsets><italic><offsets xml_i="33681" xml_f="33682" txt_i="23964" txt_f="23965">z</offsets></italic><offsets xml_i="33691" xml_f="33702" txt_i="23965" txt_f="23976"> = −5.282, </offsets><italic><offsets xml_i="33710" xml_f="33711" txt_i="23976" txt_f="23977">p</offsets></italic><offsets xml_i="33720" xml_f="33811" txt_i="23977" txt_f="24065"> &lt; 0.001), with sensitives reporting greater symptom severity (mean ± SE = 5.23 ± 1.06, </offsets><italic><offsets xml_i="33819" xml_f="33820" txt_i="24065" txt_f="24066">n</offsets></italic><offsets xml_i="33829" xml_f="33873" txt_i="24066" txt_f="24110"> = 48) and number of symptoms (4.03 ± 0.71, </offsets><italic><offsets xml_i="33881" xml_f="33882" txt_i="24110" txt_f="24111">n</offsets></italic><offsets xml_i="33891" xml_f="33965" txt_i="24111" txt_f="24185"> = 48) compared with controls (1.20 ± 0.18 and 0.92 ± 0.10, respectively; </offsets><italic><offsets xml_i="33973" xml_f="33974" txt_i="24185" txt_f="24186">n</offsets></italic><offsets xml_i="33983" xml_f="34310" txt_i="24186" txt_f="24513"> = 132). We found no overall effect for exposure. Thus, sensitives reported a greater severity and number of symptoms compared with controls, regardless of exposure condition. Symptom reporting did not change as a function of exposure condition for either group, and between-group analyses revealed no significant differences (</offsets><xref ref-type="table" rid="t5-ehp-118-735"><offsets xml_i="34354" xml_f="34361" txt_i="24513" txt_f="24520">Table 5</offsets></xref><offsets xml_i="34368" xml_f="34370" txt_i="24520" txt_f="24522">).</offsets></p></sec><sec><title><offsets xml_i="34392" xml_f="34414" txt_i="24524" txt_f="24546">Physiological measures</offsets></title><p><offsets xml_i="34425" xml_f="34735" txt_i="24547" txt_f="24857">For the open provocation test, the mean HR data were normally distributed. The five remaining means and standard deviations data were positively skewed, thus requiring transformation. The distributions for the BVP mean and SD and HR SD data showed no improvement after transformation (Kolmogorov–Smirnov test, </offsets><italic><offsets xml_i="34743" xml_f="34744" txt_i="24857" txt_f="24858">p</offsets></italic><offsets xml_i="34753" xml_f="34797" txt_i="24858" txt_f="24902"> ≤ 0.03), so we did not analyze them. We log</offsets><sub><offsets xml_i="34802" xml_f="34804" txt_i="24902" txt_f="24904">10</offsets></sub><offsets xml_i="34810" xml_f="35039" txt_i="24904" txt_f="25133">-transformed the remaining data. For the double-blind data, the BVP (mean) could not be transformed, and we did not analyze these data. HR (mean) data were normally distributed. We logarithmically transformed the remaining data (</offsets><xref ref-type="table" rid="t6-ehp-118-735"><offsets xml_i="35083" xml_f="35090" txt_i="25133" txt_f="25140">Table 6</offsets></xref><offsets xml_i="35097" xml_f="35237" txt_i="25140" txt_f="25280">). We analyzed the data using a 2 × 2 exposure (sham, TETRA) × group (sensitive, control) ANOVA for open provocation and double-blind tests.</offsets></p><p><offsets xml_i="35244" xml_f="35314" txt_i="25281" txt_f="25351">The ANOVA for HR (mean) produced a significant main effect for group (</offsets><italic><offsets xml_i="35322" xml_f="35323" txt_i="25351" txt_f="25352">p</offsets></italic><offsets xml_i="35332" xml_f="35707" txt_i="25352" txt_f="25727"> = 0.008), indicating that sensitives had higher overall HR readings (mean ± SE = 71.72 ± 1.42) than did controls (67.26 ± 0.88) during the open provocation test. None of the ANOVA results for any other variables measured during the open provocation test were significant. Under double-blind conditions, ANOVA revealed a reliable between-group difference for HR (mean) only (</offsets><italic><offsets xml_i="35715" xml_f="35716" txt_i="25727" txt_f="25728">p</offsets></italic><offsets xml_i="35725" xml_f="36000" txt_i="25728" txt_f="26003"> = 0.019). In general, HR readings were higher for sensitives (77.04 ± 1.43) than for controls (73.10 ± 0.861). However, after adjusting for type 1 error (α = 0.008), this finding was not significant. We found no other significant comparisons either within or between groups.</offsets></p></sec><sec><title><offsets xml_i="36022" xml_f="36042" txt_i="26005" txt_f="26025">“On”/“Off” judgments</offsets></title><p><offsets xml_i="36053" xml_f="36361" txt_i="26026" txt_f="26334">On four occasions judgment was required after 5 min of exposure (session 1) and on two other occasions after 50 min (sessions 2 and 3). We performed Pearson chi-square tests of successful judgments by trial × group. After correcting for multiple comparisons (α = 0.008), we found no significant differences (</offsets><xref ref-type="table" rid="t7-ehp-118-735"><offsets xml_i="36405" xml_f="36412" txt_i="26334" txt_f="26341">Table 7</offsets></xref><offsets xml_i="36419" xml_f="36620" txt_i="26341" txt_f="26542">). Results that appeared significant at α = 0.05 did not show a consistent pattern across trials. Thus, neither group could tell above chance (50%) when the base station was “on” or when it was “off.” </offsets><xref ref-type="fig" rid="f3-ehp-118-735"><offsets xml_i="36662" xml_f="36670" txt_i="26542" txt_f="26550">Figure 3</offsets></xref><offsets xml_i="36677" xml_f="37097" txt_i="26550" txt_f="26970"> presents the binomial distribution with the expected rate of success (0 of 6 correct, 1 of 6 correct, etc.) at chance compared with the observed rate of success in each group. Two sensitives and three controls correctly judged all six trials. The distribution shows a slight response bias toward “off,” with controls tending to judge the base station as “off” 57% of the time and sensitive participants 51% of the time.</offsets></p></sec></sec><sec sec-type="discussion"><title><offsets xml_i="37147" xml_f="37157" txt_i="26973" txt_f="26983">Discussion</offsets></title><p><offsets xml_i="37168" xml_f="37615" txt_i="26984" txt_f="27431">This investigation is the first to examine the short-term effects of a TETRA base station signal on human health and well-being. We found no evidence to suggest that TETRA base station signals have a negative impact on health and well-being in either the control or sensitive groups. In addition, neither group could reliably detect the presence of a TETRA signal. These findings concur with two recent studies conducted on TETRA handset signals (</offsets><xref rid="b3-ehp-118-735" ref-type="bibr"><offsets xml_i="37658" xml_f="37676" txt_i="27431" txt_f="27449">Barker et al. 2007</offsets></xref><offsets xml_i="37683" xml_f="37685" txt_i="27449" txt_f="27451">; </offsets><xref rid="b11-ehp-118-735" ref-type="bibr"><offsets xml_i="37729" xml_f="37746" txt_i="27451" txt_f="27468">Green et al. 2005</offsets></xref><offsets xml_i="37753" xml_f="37927" txt_i="27468" txt_f="27642">) as well as a growing body of evidence on GSM and UMTS signals, which found no differences between active and sham conditions and no ability to detect the presence of EMFs (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="37970" xml_f="37989" txt_i="27642" txt_f="27661">Eltiti et al. 2007a</offsets></xref><offsets xml_i="37996" xml_f="37998" txt_i="27661" txt_f="27663">; </offsets><xref rid="b15-ehp-118-735" ref-type="bibr"><offsets xml_i="38042" xml_f="38058" txt_i="27663" txt_f="27679">Kwon et al. 2008</offsets></xref><offsets xml_i="38065" xml_f="38067" txt_i="27679" txt_f="27681">; </offsets><xref rid="b18-ehp-118-735" ref-type="bibr"><offsets xml_i="38111" xml_f="38130" txt_i="27681" txt_f="27700">Lyskov et al. 2001b</offsets></xref><offsets xml_i="38137" xml_f="38139" txt_i="27700" txt_f="27702">; </offsets><xref rid="b23-ehp-118-735" ref-type="bibr"><offsets xml_i="38183" xml_f="38200" txt_i="27702" txt_f="27719">Regel et al. 2006</offsets></xref><offsets xml_i="38207" xml_f="38209" txt_i="27719" txt_f="27721">; </offsets><xref rid="b25-ehp-118-735" ref-type="bibr"><offsets xml_i="38253" xml_f="38270" txt_i="27721" txt_f="27738">Rubin et al. 2006</offsets></xref><offsets xml_i="38277" xml_f="38279" txt_i="27738" txt_f="27740">; </offsets><xref rid="b30-ehp-118-735" ref-type="bibr"><offsets xml_i="38323" xml_f="38343" txt_i="27740" txt_f="27760">Zwamborn et al. 2003</offsets></xref><offsets xml_i="38350" xml_f="38363" txt_i="27760" txt_f="27773">). Moreover, </offsets><xref rid="b26-ehp-118-735" ref-type="bibr"><offsets xml_i="38407" xml_f="38426" txt_i="27773" txt_f="27792">Rubin et al. (2010)</offsets></xref><offsets xml_i="38433" xml_f="38555" txt_i="27792" txt_f="27914"> concluded in their systematic review that the evidence linking IEI-EMF to EMFs is weaker now than in their first review (</offsets><xref rid="b24-ehp-118-735" ref-type="bibr"><offsets xml_i="38599" xml_f="38616" txt_i="27914" txt_f="27931">Rubin et al. 2005</offsets></xref><offsets xml_i="38623" xml_f="38767" txt_i="27931" txt_f="28075">). Taken together, these findings suggest that RF-EMFs in the range of approximately 400–2100 MHz do not have a negative impact on human health.</offsets></p><p><offsets xml_i="38774" xml_f="40222" txt_i="28076" txt_f="29524">This study has some limitations. Our study tested individuals who identified themselves as sensitive to EMFs. Unlike a handset, which one can know to be on or off, reporting a sensitivity specifically to the TETRA base station signal is difficult, because it is unlikely that one can know where the signal is coming from. Therefore, this study addresses the general question of whether people with a perceived sensitivity to EMFs are affected by TETRA. We did not ascertain the exact onset of symptoms for each sensitive participant, and our study does not address long-term consequences of EMF exposure. We were not able to recruit the target number of sensitive participants in the 2.5-year period of funding for the study. Even with these caveats, we had sufficient power to detect a reliable difference in the open provocation condition. When participants knew they were being exposed to a TETRA signal, we found changes in most measures, but these results were not replicated under double-blind conditions. Sensitive participants continued to report more symptoms and experienced a greater overall severity of symptoms than did controls, but this effect was independent of exposure condition. This pattern of results replicates our previous findings using GSM and UMTS signals, which showed that only during open provocation conditions did sensitive participants report increased symptom and reduced well-being under active signal conditions (</offsets><xref rid="b8-ehp-118-735" ref-type="bibr"><offsets xml_i="40265" xml_f="40284" txt_i="29524" txt_f="29543">Eltiti et al. 2007a</offsets></xref><offsets xml_i="40291" xml_f="40437" txt_i="29543" txt_f="29689">). Overall, these results suggest that it is not acute exposure to a base station signal that causes symptoms, but the knowledge of that exposure.</offsets></p><p><offsets xml_i="40444" xml_f="41009" txt_i="29690" txt_f="30255">The long-term health consequences of EMF exposure are most often associated with physical health risks such as cancer. However, the long-term consequences of prolonged stress and anxiety that accompany the expectations associated with the everyday experiences of IEI-EMF individuals may be equally serious and, to our knowledge, have not been studied. For example, evidence suggests that ongoing worry is associated with low HR variability and increased HR during waking and sleeping, which, in turn, is associated with an increased risk of cardiovascular disease (</offsets><xref rid="b6-ehp-118-735" ref-type="bibr"><offsets xml_i="41052" xml_f="41073" txt_i="30255" txt_f="30276">Brosschot et al. 2007</offsets></xref><offsets xml_i="41080" xml_f="41290" txt_i="30276" txt_f="30486">). Such findings indicate the importance of cognitive factors in IEI-EMF. Therefore, we recommend that future research should include a case–control study to elucidate the long-term impact of IEI-EMF on health.</offsets></p></sec></body><back><fn-group><fn><p>We thank our participants, especially the electrosensitive individuals, for their contribution to our study. We also thank Red-M [West Sussex, United Kingdom (<ext-link ext-link-type="uri" xlink:href="http://www.red-m.com/">http://www.red-m.com/</ext-link>)], which developed and produced the exposure system for us, as well as the National Physical Laboratory of the United Kingdom for supplying the screened rooms and providing independent measurements and testing of both the exposure system and experimental environment.</p></fn><fn><p>This work was funded by the Mobile Telecommunication and Health Research Programme (grant RUM 26) that supports teams of independent scientists in the United Kingdom to investigate various aspects of mobile phone technologies on human and animal health.</p></fn><fn><p>Funding for this program comes from both industry and government sources, and a firewall exists to ensure that the funders have no say in the scientific groups that receive funding and no input into the design of the studies supported or where and when the results are published.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ehp-118-735"><element-citation publication-type="webpage"><collab>Advisory Group on Non-Ionizing Radiation</collab><year>2001</year><article-title>Possible Health Effects from Terrestrial Trunked Radio (Tetra): Report of an Advisory Group on non-ionizing radiation: NRPB</article-title><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947336937">http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947336937</ext-link></comment><date-in-citation>[accessed 7 December 2009]</date-in-citation></element-citation></ref><ref id="b2-ehp-118-735"><element-citation publication-type="webpage"><collab>Airwave Health Monitoring Study</collab><year>2009</year><source>Airwave Health Monitoring Study Home Page</source><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.police-health.org.uk/">http://www.police-health.org.uk/</ext-link></comment><date-in-citation>[accessed 15 July 2009]</date-in-citation></element-citation></ref><ref id="b3-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>P</given-names></name><name><surname>Parry</surname><given-names>H</given-names></name><name><surname>Coulton</surname><given-names>L</given-names></name><name><surname>Cook</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name></person-group><year>2007</year><article-title>The effect of GSM and TETRA mobile handset signals on blood pressure, catechol levels and heart rate variability</article-title><source>Bioelectromagnetics</source><volume>28</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">17486598</pub-id></element-citation></ref><ref id="b4-ehp-118-735"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Belloul</surname><given-names>B</given-names></name></person-group><year>2008</year><source>TETRA Base Station Emulator at the University of Essex Technical Reference Manual. Version 1.4</source><publisher-loc>Colchester, UK</publisher-loc><publisher-name>University of Essex</publisher-name></element-citation></ref><ref id="b5-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blettner</surname><given-names>M</given-names></name><name><surname>Schlehofer</surname><given-names>B</given-names></name><name><surname>Breckenkamp</surname><given-names>J</given-names></name><name><surname>Kowall</surname><given-names>B</given-names></name><name><surname>Schmiedel</surname><given-names>S</given-names></name><name><surname>Reis</surname><given-names>U</given-names></name><etal></etal></person-group><year>2009</year><article-title>Mobile phone base stations and adverse health effects: phase 1 of a population-based, cross-sectional study in Germany</article-title><source>Occup Environ Med</source><volume>66</volume><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">19017702</pub-id></element-citation></ref><ref id="b6-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosschot</surname><given-names>JF</given-names></name><name><surname>Van Dijk</surname><given-names>E</given-names></name><name><surname>Thayer</surname><given-names>JF</given-names></name></person-group><year>2007</year><article-title>Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period</article-title><source>Int J Psychophysiol</source><volume>63</volume><issue>1</issue><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17020787</pub-id></element-citation></ref><ref id="b7-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challis</surname><given-names>L</given-names></name></person-group><year>2005</year><article-title>Mechanisms for interaction between RF fields and biological tissue</article-title><source>Bioelectromagnetics</source><volume>7</volume><issue>suppl</issue><fpage>S98</fpage><lpage>S106</lpage><pub-id pub-id-type="pmid">15931683</pub-id></element-citation></ref><ref id="b8-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltiti</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>D</given-names></name><name><surname>Ridgewell</surname><given-names>A</given-names></name><name><surname>Zougkou</surname><given-names>K</given-names></name><name><surname>Russo</surname><given-names>R</given-names></name><name><surname>Sepulveda</surname><given-names>F</given-names></name><etal></etal></person-group><year>2007a</year><article-title>Does short-term exposure to mobile phone base station signals increase symptoms in individuals who report sensitivity to electromagnetic fields? A double-blind randomized provocation study</article-title><source>Environ Health Perspect</source><volume>115</volume><fpage>1603</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">18007992</pub-id></element-citation></ref><ref id="b9-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltiti</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>D</given-names></name><name><surname>Zougkou</surname><given-names>K</given-names></name><name><surname>Russo</surname><given-names>R</given-names></name><name><surname>Joseph</surname><given-names>S</given-names></name><name><surname>Rasor</surname><given-names>P</given-names></name><etal></etal></person-group><year>2007b</year><article-title>Development and evaluation of the electromagnetic hypersensitivity questionnaire</article-title><source>Bioelectromagnetics</source><volume>28</volume><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">17013888</pub-id></element-citation></ref><ref id="b10-ehp-118-735"><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>N</given-names></name></person-group><year>2002</year><article-title>UK Police Sick of TETRA Handsets</article-title><source>V3.co.uk</source><day>18</day><month>7</month><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.vnunet.com/vnunet/news/2119506/uk-police-sick-tetra-handsets">http://www.vnunet.com/vnunet/news/2119506/uk-police-sick-tetra-handsets</ext-link></comment><date-in-citation>[accessed 10 July 2009]</date-in-citation></element-citation></ref><ref id="b11-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>I</given-names></name><name><surname>Gwyther</surname><given-names>R</given-names></name><name><surname>Peyman</surname><given-names>A</given-names></name><name><surname>Chadwick</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><etal></etal></person-group><year>2005</year><article-title>An investigation of the effects of TETRA RF fields on intracellular calcium in neurones and cardiac myocytes</article-title><source>Int J Radiat Biol</source><volume>81</volume><fpage>869</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">16524843</pub-id></element-citation></ref><ref id="b12-ehp-118-735"><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Hansson Mild</surname><given-names>K</given-names></name><name><surname>Repacholi</surname><given-names>M</given-names></name><name><surname>Van Deventer</surname><given-names>E</given-names></name><name><surname>Ravazzani</surname><given-names>P</given-names></name></person-group><year>2006</year><article-title>Working group report</article-title><source>Proceedings, International Workshop on EMF Hypersensitivity, Prague, Czech Republic</source><month>10</month><day>25–27</day><year>2004</year><comment>(Hansson Mild K, Repacholi M, van Deventer E, Ravazzani P, eds)</comment><publisher-loc>Milan</publisher-loc><publisher-name>World Health Organization</publisher-name><fpage>15</fpage><lpage>26</lpage><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/peh-emf/publications/reports/EHS_Proceedings_June2006.pdf">http://www.who.int/peh-emf/publications/reports/EHS_Proceedings_June2006.pdf</ext-link></comment><date-in-citation>[accessed 1 July 2009]</date-in-citation></element-citation></ref><ref id="b13-ehp-118-735"><element-citation publication-type="journal"><collab>International Commission on Non-Ionizing Radiation Protection</collab><year>1998</year><article-title>Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz)</article-title><source>Health Phys</source><volume>74</volume><fpage>494</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">9525427</pub-id></element-citation></ref><ref id="b14-ehp-118-735"><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>N</given-names></name></person-group><year>2005</year><article-title>Definition, Epidemiology and Management of Electrical Sensitivity: Report for the Radiation Protection Division of the Health Protection Agency</article-title><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/webw/HPAweb&amp;HPAwebStandard/HPAweb_C/1247816558210?p=1197637096018">http://www.hpa.org.uk/webw/HPAweb&amp;HPAwebStandard/HPAweb_C/1247816558210?p=1197637096018</ext-link></comment><date-in-citation>[accessed 2 June 2009]</date-in-citation></element-citation></ref><ref id="b15-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>MS</given-names></name><name><surname>Koivisto</surname><given-names>M</given-names></name><name><surname>Laine</surname><given-names>M</given-names></name><name><surname>Hämäläinen</surname><given-names>H</given-names></name></person-group><year>2008</year><article-title>Perception of the electromagnetic field emitted by a mobile phone</article-title><source>Bioelectromagnetics</source><volume>29</volume><fpage>154</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">18027840</pub-id></element-citation></ref><ref id="b16-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landgrebe</surname><given-names>M</given-names></name><name><surname>Barta</surname><given-names>W</given-names></name><name><surname>Rosengarth</surname><given-names>K</given-names></name><name><surname>Frick</surname><given-names>U</given-names></name><name><surname>Hauser</surname><given-names>S</given-names></name><name><surname>Langguth</surname><given-names>B</given-names></name><etal></etal></person-group><year>2008</year><article-title>Neuronal correlates of symptom formation in functional somatic syndromes: a fMRI study</article-title><source>NeuroImage</source><volume>41</volume><fpage>1336</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">18499479</pub-id></element-citation></ref><ref id="b17-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyskov</surname><given-names>E</given-names></name><name><surname>Sandström</surname><given-names>M</given-names></name><name><surname>Hansson Mild</surname><given-names>K</given-names></name></person-group><year>2001a</year><article-title>Neurophysiological study of patients with perceived ‘electrical hypersensitivity’</article-title><source>Int J Psychophysiol</source><volume>42</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">11812390</pub-id></element-citation></ref><ref id="b18-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyskov</surname><given-names>E</given-names></name><name><surname>Sandström</surname><given-names>M</given-names></name><name><surname>Hansson Mild</surname><given-names>K</given-names></name></person-group><year>2001b</year><article-title>Provocation study of persons with perceived electrical hypersensitivity and controls using magnetic field exposure and recording of electrophysiological characteristics</article-title><source>Bioelectromagnetics</source><volume>22</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">11568930</pub-id></element-citation></ref><ref id="b19-ehp-118-735"><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>T</given-names></name><name><surname>Allen</surname><given-names>S</given-names></name><name><surname>Blackwell</surname><given-names>R</given-names></name><name><surname>Lowe</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Exposure to Radio Waves near Mobile Phone Base Stations</article-title><source>Report no. NRPB-R321</source><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947399556">http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947399556</ext-link></comment><date-in-citation>[accessed 3 June 2009]</date-in-citation></element-citation></ref><ref id="b20-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>SMJ</given-names></name><name><surname>Ahmadi</surname><given-names>J</given-names></name><name><surname>Shariati</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Prevalence of subjective poor health symptoms associated with exposure to electromagnetic fields among university students</article-title><source>Bioelectromagnetics</source><volume>28</volume><fpage>326</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">17330851</pub-id></element-citation></ref><ref id="b21-ehp-118-735"><element-citation publication-type="journal"><collab>NRPB (National Radiological Protection Board)</collab><year>2001</year><article-title>Possible Health Effects from Terrestrial Trunked Radio (TETRA): Report of an Advisory Group on Non-ionizing Radiation</article-title><volume>12</volume><issue>2</issue><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947336937">http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947336937</ext-link></comment><date-in-citation>[accessed 7 December 2009]</date-in-citation></element-citation></ref><ref id="b22-ehp-118-735"><element-citation publication-type="webpage"><collab>Police Federation News</collab><year>2005</year><source>Airwave, Keeping the Lines of Communication Open?</source><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.polfed.org/PFNews_Airwave_Issue24.pdf">http://www.polfed.org/PFNews_Airwave_Issue24.pdf</ext-link></comment><date-in-citation>[accessed 3 June 2009]</date-in-citation></element-citation></ref><ref id="b23-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regel</surname><given-names>S</given-names></name><name><surname>Negovetic</surname><given-names>S</given-names></name><name><surname>Röösli</surname><given-names>M</given-names></name><name><surname>Berdiñas</surname><given-names>V</given-names></name><name><surname>Schuderer</surname><given-names>J</given-names></name><name><surname>Huss</surname><given-names>A</given-names></name><etal></etal></person-group><year>2006</year><article-title>UMTS base station-like exposure, well-being, and cognitive performance</article-title><source>Environ Health Perspect</source><volume>114</volume><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="pmid">16882538</pub-id></element-citation></ref><ref id="b24-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>G</given-names></name><name><surname>Das Munshi</surname><given-names>J</given-names></name><name><surname>Wessely</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Electromagnetic hypersensitivity: a systematic review of provocation studies</article-title><source>Psychosom Med</source><volume>67</volume><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">15784787</pub-id></element-citation></ref><ref id="b25-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>G</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name><name><surname>Everitt</surname><given-names>B</given-names></name><name><surname>Cleare</surname><given-names>A</given-names></name><name><surname>Wessely</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Are some people sensitive to mobile phone signals? Within participants double blind randomised provocation study</article-title><source>BMJ</source><volume>332</volume><fpage>886</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">16520326</pub-id></element-citation></ref><ref id="b26-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>GJ</given-names></name><name><surname>Nieto-Hernandez</surname><given-names>R</given-names></name><name><surname>Wessely</surname><given-names>S</given-names></name></person-group><year>2010</year><article-title>Idiopathic environmental intolerance attributed to electromagnetic fields (formerly ‘electromagnetic hypersensitivity’): an updated systematic review of provocation studies</article-title><source>Bioelectromagnetics</source><volume>31</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">19681059</pub-id></element-citation></ref><ref id="b27-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandström</surname><given-names>M</given-names></name><name><surname>Lyskov</surname><given-names>E</given-names></name><name><surname>Hörnsten</surname><given-names>R</given-names></name><name><surname>Hansson Mild</surname><given-names>K</given-names></name><name><surname>Wiklund</surname><given-names>U</given-names></name><name><surname>Rask</surname><given-names>P</given-names></name><etal></etal></person-group><year>2003</year><article-title>Holter ECG monitoring in patients with perceived electrical hypersensitivity</article-title><source>Int J Psychophysiol</source><volume>49</volume><fpage>227</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">14507441</pub-id></element-citation></ref><ref id="b28-ehp-118-735"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valberg</surname><given-names>P</given-names></name><name><surname>van Deventer</surname><given-names>E</given-names></name><name><surname>Repacholi</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Workgroup report: base stations and wireless networks-radiofrequency (RF) exposures and health consequences</article-title><source>Environ Health Perspect</source><volume>115</volume><fpage>416</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">17431492</pub-id></element-citation></ref><ref id="b29-ehp-118-735"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>D</given-names></name></person-group><year>1981</year><source>Wechsler Adult Intelligence Scale–Revised</source><publisher-loc>New York</publisher-loc><publisher-name>Psychological Corporation</publisher-name></element-citation></ref><ref id="b30-ehp-118-735"><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Zwamborn</surname><given-names>A</given-names></name><name><surname>Vossen</surname><given-names>S</given-names></name><name><surname>van Leersum</surname><given-names>B</given-names></name><name><surname>Ouwens</surname><given-names>M</given-names></name><name><surname>Mäkel</surname><given-names>W</given-names></name></person-group><year>2003</year><article-title>Effects of Global Communication System Radio-Frequency Fields on Well Being and Cognitive Functions of Human Subjects with and without Subjective Complaints</article-title><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.rivm.nl/milieuportaal/images/Zwamborn2003COFAMrapport.pdf">http://www.rivm.nl/milieuportaal/images/Zwamborn2003COFAMrapport.pdf</ext-link></comment><date-in-citation>[accessed 10 July 2009]</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig id="f1-ehp-118-735" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Diagram of the exposure chamber.</p></caption><graphic xlink:href="ehp-118-735f1"></graphic></fig><fig id="f2-ehp-118-735" orientation="portrait" position="float"><label></label><caption><p>Flow of participants through each stage of testing. Five data sets from the 144 controls that completed the open provocation test were incomplete because of technical problems, and six males were randomly replaced with 6 females to achieve matching by sex. These 11 data sets plus the data set of the person who withdrew after session 1 (total of 12) were not analyzed.</p></caption><graphic xlink:href="ehp-118-735f2"></graphic></fig><fig id="f3-ehp-118-735" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The probability of getting 0–6 of 6 correct: shown as a percentage by group of expected outcome versus observed outcome. (<italic>A</italic>) Controls (<italic>n</italic> = 132). (<italic>B</italic>) Sensitives (<italic>n</italic> = 48).</p></caption><graphic xlink:href="ehp-118-735f3"></graphic></fig><table-wrap id="t1-ehp-118-735" orientation="portrait" position="float"><label>Table 1</label><caption><p>Procedures for open provocation and double-blind tests.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1"></th><th align="center" valign="bottom" rowspan="1" colspan="1">Task</th><th align="center" valign="bottom" rowspan="1" colspan="1">Duration</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="top" rowspan="1">Session 1<hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Background information</td><td align="left" valign="top" rowspan="1" colspan="1">Medical history interview, psychologic questionnaires, WAIS-R verbal memory test</td><td align="left" valign="top" rowspan="1" colspan="1">1 hr</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Open provocation (e.g., sham, TETRA)</td><td align="left" valign="top" rowspan="1" colspan="1">VAS completed every 5 min, symptoms reported, physiologic measurements taken continuously</td><td align="left" valign="top" rowspan="1" colspan="1">15 min for each exposure; 2-min “washout” between exposures</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cognitive tests</td><td align="left" valign="top" rowspan="1" colspan="1">Participants completed Backward Digit Span Task and Letter Cancellation Task</td><td align="left" valign="top" rowspan="1" colspan="1">8 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Double-blind trials (e.g., sham, sham, TETRA, TETRA)</td><td align="left" valign="top" rowspan="1" colspan="1">At the end of each of the four short-duration trials, participants specified whether they believed the base station had been “on” or “off” and how confident of this judgment they were</td><td align="left" valign="top" rowspan="1" colspan="1">5 min for each exposure; 2-min “washout” between exposures</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr></hr></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Session 2 and 3, double-blind (e.g., session 2, TETRA; session 3, sham)<hr></hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exposure per session (TETRA/sham)</td><td align="left" valign="top" rowspan="1" colspan="1">Physiologic measurements were taken continuously over the entire exposure period</td><td align="left" valign="top" rowspan="1" colspan="1">50 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Low load</td><td align="left" valign="top" rowspan="1" colspan="1">Participants watched <italic>Planet Earth</italic> DVD, completed VAS every 5 min, and recorded any symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">20 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">High load</td><td align="left" valign="top" rowspan="1" colspan="1">Participants performed an operation span task; the task was interrupted every 5 min to allow for the completion of VAS and symptom scales</td><td align="left" valign="top" rowspan="1" colspan="1">20 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cognitive tests</td><td align="left" valign="top" rowspan="1" colspan="1">Participants completed Backward Digit Span Task and Letter Cancellation Task</td><td align="left" valign="top" rowspan="1" colspan="1">8 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">On/off judgment</td><td align="left" valign="top" rowspan="1" colspan="1">Participants made a judgment as to whether the base station was “on” or “off”; procedure was identical to session 1</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ehp-118-735"><p>WAIS-R, Wechsler Adult Intelligence Scale–Revised (<xref rid="b29-ehp-118-735" ref-type="bibr">Wechsler 1981</xref>). Standard cognitive tests were administered to assess whether the TETRA signal affects memory and attention. The results will be reported in a separate article.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ehp-118-735" orientation="portrait" position="float"><label>Table 2</label><caption><p>Additional health and social behavior information [<italic>n</italic> (%)].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1"></th><th colspan="2" align="center" valign="bottom" rowspan="1">Yes<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">No<hr></hr></th><th align="center" valign="bottom" rowspan="1" colspan="1"></th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive (<italic>n</italic>= 51)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control (<italic>n</italic>= 132)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive (<italic>n</italic>= 51)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control (<italic>n</italic>= 132)</th><th align="center" valign="bottom" rowspan="1" colspan="1">χ<sup>2</sup><xref ref-type="table-fn" rid="tfn2-ehp-118-735">a</xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic illness</td><td align="left" valign="top" rowspan="1" colspan="1">5 (9.8)</td><td align="right" valign="top" rowspan="1" colspan="1">15 (11.4)</td><td align="left" valign="top" rowspan="1" colspan="1">46 (90.2)</td><td align="right" valign="top" rowspan="1" colspan="1">117 (88.6)</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Headache-prone<xref ref-type="table-fn" rid="tfn3-ehp-118-735">b</xref></td><td align="left" valign="top" rowspan="1" colspan="1">24 (47.1)</td><td align="right" valign="top" rowspan="1" colspan="1">25 (18.9)</td><td align="left" valign="top" rowspan="1" colspan="1">27 (52.9)</td><td align="right" valign="top" rowspan="1" colspan="1">100 (75.8)</td><td align="center" valign="top" rowspan="1" colspan="1">11.9<xref ref-type="table-fn" rid="tfn5-ehp-118-735">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Taking medication</td><td align="left" valign="top" rowspan="1" colspan="1">21 (41.2)</td><td align="right" valign="top" rowspan="1" colspan="1">59 (44.7)</td><td align="left" valign="top" rowspan="1" colspan="1">30 (58.8)</td><td align="right" valign="top" rowspan="1" colspan="1">73 (55.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Electric shock<xref ref-type="table-fn" rid="tfn4-ehp-118-735">c</xref></td><td align="left" valign="top" rowspan="1" colspan="1">15 (29.4)</td><td align="right" valign="top" rowspan="1" colspan="1">23 (17.4)</td><td align="left" valign="top" rowspan="1" colspan="1">34 (66.7)</td><td align="right" valign="top" rowspan="1" colspan="1">109 (82.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2.99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smoker</td><td align="left" valign="top" rowspan="1" colspan="1">6 (11.8)</td><td align="right" valign="top" rowspan="1" colspan="1">14 (10.6)</td><td align="left" valign="top" rowspan="1" colspan="1">45 (88.2)</td><td align="right" valign="top" rowspan="1" colspan="1">118 (89.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Consumes alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">41 (80.4)</td><td align="right" valign="top" rowspan="1" colspan="1">108 (81.8)</td><td align="left" valign="top" rowspan="1" colspan="1">10 (19.6)</td><td align="right" valign="top" rowspan="1" colspan="1">24 (18.2)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ehp-118-735"><label>a</label><p>Values reflect χ<sup>2</sup> with Yates continuity corrections; <italic>p</italic>-values with or without this correction are very similar.</p></fn><fn id="tfn3-ehp-118-735"><label>b</label><p>Missing data for 7 (5.3%) control participants.</p></fn><fn id="tfn4-ehp-118-735"><label>c</label><p>Missing data for 2 (3.9%) sensitive participants.</p></fn><fn id="tfn5-ehp-118-735"><label>*</label><p><italic>p</italic> &lt; 0.008 (Bonferroni corrected α = 0.008).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ehp-118-735" orientation="portrait" position="float"><label>Table 3</label><caption><p>Descriptives (means ± SEs) and statistical tests (<italic>z</italic>-scores) for the open provocation VAS for sensitive and control participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">VAS measure</th><th colspan="2" align="center" valign="bottom" rowspan="1">Sham<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">Difference score<xref ref-type="table-fn" rid="tfn7-ehp-118-735">a</xref><hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA vs. sham<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive vs. control difference score<xref ref-type="table-fn" rid="tfn9-ehp-118-735">c</xref></th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive<xref ref-type="table-fn" rid="tfn8-ehp-118-735">b</xref></th><th align="center" valign="bottom" rowspan="1" colspan="1">Control<xref ref-type="table-fn" rid="tfn8-ehp-118-735">b</xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Anxiety</td><td align="center" valign="top" rowspan="1" colspan="1">1.51 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">0.99 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">2.24 ± 0.27</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 ± 0.11</td><td align="right" valign="top" rowspan="1" colspan="1">0.72 ± 0.16</td><td align="right" valign="top" rowspan="1" colspan="1">0.13 ± 0.07</td><td align="left" valign="top" rowspan="1" colspan="1">−4.022<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.650<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.935<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tension</td><td align="center" valign="top" rowspan="1" colspan="1">1.51 ± 0.23</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">2.31 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.20 ± 0.12</td><td align="right" valign="top" rowspan="1" colspan="1">0.80 ± 0.18</td><td align="right" valign="top" rowspan="1" colspan="1">0.20 ± 0.06</td><td align="left" valign="top" rowspan="1" colspan="1">−4.442<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.325<xref ref-type="table-fn" rid="tfn11-ehp-118-735">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−3.879<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Arousal</td><td align="center" valign="top" rowspan="1" colspan="1">1.54 ± 0.23</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">2.20 ± 0.27</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 ± 0.11</td><td align="right" valign="top" rowspan="1" colspan="1">0.66 ± 0.17</td><td align="right" valign="top" rowspan="1" colspan="1">0.16 ± 0.06</td><td align="left" valign="top" rowspan="1" colspan="1">−4.170<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−1.527</td><td align="left" valign="top" rowspan="1" colspan="1">−3.852<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">1.92 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.25 ± 0.11</td><td align="center" valign="top" rowspan="1" colspan="1">2.71 ± 0.31</td><td align="center" valign="top" rowspan="1" colspan="1">1.41 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">0.79 ± 0.24</td><td align="right" valign="top" rowspan="1" colspan="1">0.16 ± 0.06</td><td align="left" valign="top" rowspan="1" colspan="1">−3.244<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.533<xref ref-type="table-fn" rid="tfn12-ehp-118-735">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.903<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td><td align="center" valign="top" rowspan="1" colspan="1">3.05 ± 0.34</td><td align="center" valign="top" rowspan="1" colspan="1">2.04 ± 0.17</td><td align="center" valign="top" rowspan="1" colspan="1">3.18 ± 0.34</td><td align="center" valign="top" rowspan="1" colspan="1">2.12 ± 0.17</td><td align="right" valign="top" rowspan="1" colspan="1">0.13 ± 0.21</td><td align="right" valign="top" rowspan="1" colspan="1">0.08 ± 0.10</td><td align="left" valign="top" rowspan="1" colspan="1">−1.244</td><td align="left" valign="top" rowspan="1" colspan="1">−1.628</td><td align="left" valign="top" rowspan="1" colspan="1">−0.792</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Relaxation<xref ref-type="table-fn" rid="tfn10-ehp-118-735">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7.44 ± 0.28</td><td align="center" valign="top" rowspan="1" colspan="1">8.16 ± 0.15</td><td align="center" valign="top" rowspan="1" colspan="1">6.65 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">7.94 ± 0.16</td><td align="right" valign="top" rowspan="1" colspan="1">−0.79 ± 0.24</td><td align="right" valign="top" rowspan="1" colspan="1">−0.22 ± 0.08</td><td align="left" valign="top" rowspan="1" colspan="1">−3.478<xref ref-type="table-fn" rid="tfn13-ehp-118-735">#</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.032<xref ref-type="table-fn" rid="tfn11-ehp-118-735">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">−2.367<xref ref-type="table-fn" rid="tfn11-ehp-118-735">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ehp-118-735"><p>All data were analyzed using corresponding <italic>t</italic>-tests with very similar results.</p></fn><fn id="tfn7-ehp-118-735"><label>a</label><p>Difference score mean ± SE: TETRA – sham; positive value indicates TETRA &gt; sham.</p></fn><fn id="tfn8-ehp-118-735"><label>b</label><p><italic>z</italic>, Wilcoxon signed rank test.</p></fn><fn id="tfn9-ehp-118-735"><label>c</label><p><italic>z</italic>, Mann-Whitney <italic>U</italic>-test.</p></fn><fn id="tfn10-ehp-118-735"><label>d</label><p>Relaxation is reversed; therefore, a high score tends toward “extremely” relaxed.</p></fn><fn id="tfn11-ehp-118-735"><label>*</label><p><italic>p</italic> ≤ 0.05.</p></fn><fn id="tfn12-ehp-118-735"><label>**</label><p><italic>p</italic> ≤ 0.01.</p></fn><fn id="tfn13-ehp-118-735"><label>#</label><p><italic>p</italic> &lt; 0.008 (Bonferroni corrected α = 0.008).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-ehp-118-735" orientation="portrait" position="float"><label>Table 4</label><caption><p>Descriptives (means ± SEs) and statistical tests (<italic>z</italic>-scores) for the double-blind VAS for sensitive and control participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="3" colspan="1">VAS measure</th><th colspan="4" align="center" valign="bottom" rowspan="1">Sham<hr></hr></th><th colspan="4" align="center" valign="bottom" rowspan="1">TETRA<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="2">Difference score<xref ref-type="table-fn" rid="tfn15-ehp-118-735">a</xref><hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="2">TETRA vs. sham<hr></hr></th><th align="center" valign="bottom" rowspan="3" colspan="1">Sensitive vs. control difference score<xref ref-type="table-fn" rid="tfn17-ehp-118-735">c</xref></th></tr><tr><th colspan="2" align="center" valign="bottom" rowspan="1">Sham BL<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="2" colspan="1">Control</th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA BL<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="2" colspan="1">Control</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="right" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="right" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive<xref ref-type="table-fn" rid="tfn16-ehp-118-735">b</xref></th><th align="center" valign="bottom" rowspan="1" colspan="1">Control<xref ref-type="table-fn" rid="tfn16-ehp-118-735">b</xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Anxiety</td><td align="center" valign="top" rowspan="1" colspan="1">1.46 ± 0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.95 ± 0.24</td><td align="center" valign="top" rowspan="1" colspan="1">1.13 ± 0.08</td><td align="center" valign="top" rowspan="1" colspan="1">1.18 ± 0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.63 ± 0.23</td><td align="center" valign="top" rowspan="1" colspan="1">1.14 ± 0.09</td><td align="right" valign="top" rowspan="1" colspan="1">−0.03 ± 0.37</td><td align="right" valign="top" rowspan="1" colspan="1">0.04 ± 0.14</td><td align="center" valign="top" rowspan="1" colspan="1">−0.144</td><td align="center" valign="top" rowspan="1" colspan="1">−0.308</td><td align="center" valign="top" rowspan="1" colspan="1">−0.128</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tension</td><td align="center" valign="top" rowspan="1" colspan="1">1.52 ± 0.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">2.06 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">1.20 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.23 ± 0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">1.73 ± 0.23</td><td align="center" valign="top" rowspan="1" colspan="1">1.16 ± 0.09</td><td align="right" valign="top" rowspan="1" colspan="1">−0.03 ± 0.36</td><td align="right" valign="top" rowspan="1" colspan="1">−0.05 ± 0.05</td><td align="center" valign="top" rowspan="1" colspan="1">−0.056</td><td align="center" valign="top" rowspan="1" colspan="1">−0.110</td><td align="center" valign="top" rowspan="1" colspan="1">−0.061</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Arousal</td><td align="center" valign="top" rowspan="1" colspan="1">1.41 ± 0.24</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">2.12 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">1.15 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.16 ± 0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.77 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">1.21 ± 0.11</td><td align="right" valign="top" rowspan="1" colspan="1">−0.11 ± 0.37</td><td align="right" valign="top" rowspan="1" colspan="1">0.22 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">−0.056</td><td align="center" valign="top" rowspan="1" colspan="1">−1.380</td><td align="center" valign="top" rowspan="1" colspan="1">−0.636</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">1.42 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">2.07 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.09 ± 0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.88 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.67 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 ± 0.10</td><td align="right" valign="top" rowspan="1" colspan="1">−0.07 ± 0.32</td><td align="right" valign="top" rowspan="1" colspan="1">0.09 ± 0.09</td><td align="center" valign="top" rowspan="1" colspan="1">−0.210</td><td align="center" valign="top" rowspan="1" colspan="1">−0.580</td><td align="center" valign="top" rowspan="1" colspan="1">−0.639</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td><td align="center" valign="top" rowspan="1" colspan="1">2.17 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.49 ± .014</td><td align="center" valign="top" rowspan="1" colspan="1">2.70 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.60 ± 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">2.25 ± 0.27</td><td align="center" valign="top" rowspan="1" colspan="1">1.33 ± 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">2.58 ± 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.51 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">−0.20 ± 0.45</td><td align="right" valign="top" rowspan="1" colspan="1">0.07 ± 0.07</td><td align="center" valign="top" rowspan="1" colspan="1">−0.338</td><td align="center" valign="top" rowspan="1" colspan="1">−0.551</td><td align="center" valign="top" rowspan="1" colspan="1">−0.615</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Relaxation<xref ref-type="table-fn" rid="tfn18-ehp-118-735">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7.70 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">8.39 ± 0.12</td><td align="center" valign="top" rowspan="1" colspan="1">6.00 ± 0.25</td><td align="center" valign="top" rowspan="1" colspan="1">6.74 ± 0.12</td><td align="center" valign="top" rowspan="1" colspan="1">7.78 ± 0.26</td><td align="center" valign="top" rowspan="1" colspan="1">8.40 ± 0.12</td><td align="center" valign="top" rowspan="1" colspan="1">6.34 ± 0.24</td><td align="center" valign="top" rowspan="1" colspan="1">6.91 ± 0.14</td><td align="right" valign="top" rowspan="1" colspan="1">0.25 ± 0.48</td><td align="right" valign="top" rowspan="1" colspan="1">0.16 ± 0.16</td><td align="center" valign="top" rowspan="1" colspan="1">−0.072</td><td align="center" valign="top" rowspan="1" colspan="1">−1.100</td><td align="center" valign="top" rowspan="1" colspan="1">−0.670</td></tr></tbody></table><table-wrap-foot><fn id="tfn14-ehp-118-735"><p>BL, baseline. All data were analyzed using corresponding <italic>t</italic>-tests with very similar results.</p></fn><fn id="tfn15-ehp-118-735"><label>a</label><p>Difference score mean ± SE for double-blind tests = (TETRA – TETRA baseline) – (sham – sham baseline); positive value indicates TETRA &gt; sham.</p></fn><fn id="tfn16-ehp-118-735"><label>b</label><p>Double-blind within-group analyses were performed on the difference between exposure and baseline scores using Wilcoxon sign rank tests [i.e., (TETRA – baseline) vs. (sham – baseline)].</p></fn><fn id="tfn17-ehp-118-735"><label>c</label><p>Double-blind between-group analyses were performed on the difference of the difference scores using Mann–Whitney <italic>U</italic>-tests; that is, sensitive (TETRA – baseline) – (sham – baseline) vs. control (TETRA – baseline) – (sham – baseline).</p></fn><fn id="tfn18-ehp-118-735"><label>d</label><p>Relaxation is reversed; therefore, a high score tends toward “extremely” relaxed.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-ehp-118-735" orientation="portrait" position="float"><label>Table 5</label><caption><p>Symptom scales descriptives (means ± SEs) and statistical tests (<italic>z</italic>-scores) for the open provocation and double-blind tests for sensitive and control participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">Test</th><th colspan="2" align="center" valign="bottom" rowspan="1">Sham<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">Difference score<xref ref-type="table-fn" rid="tfn19-ehp-118-735">a</xref><hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA vs. sham<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive vs. control difference score<xref ref-type="table-fn" rid="tfn21-ehp-118-735">c</xref></th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive<xref ref-type="table-fn" rid="tfn20-ehp-118-735">b</xref></th><th align="center" valign="bottom" rowspan="1" colspan="1">Control<xref ref-type="table-fn" rid="tfn20-ehp-118-735">b</xref></th></tr></thead><tbody><tr><td colspan="10" align="left" valign="top" rowspan="1">Open provocation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Total symptom score</td><td align="center" valign="top" rowspan="1" colspan="1">3.94 ± 1.00</td><td align="center" valign="top" rowspan="1" colspan="1">1.13 ± 0.19</td><td align="center" valign="top" rowspan="1" colspan="1">7.90 ± 1.75</td><td align="center" valign="top" rowspan="1" colspan="1">0.95 ± 0.19</td><td align="right" valign="top" rowspan="1" colspan="1">3.96 ± 1.44</td><td align="right" valign="top" rowspan="1" colspan="1">−0.17 ± 0.18</td><td align="right" valign="top" rowspan="1" colspan="1">−3.586<xref ref-type="table-fn" rid="tfn22-ehp-118-735">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">−0.973</td><td align="left" valign="top" rowspan="1" colspan="1">−4.957<xref ref-type="table-fn" rid="tfn22-ehp-118-735">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Total number of symptoms reported</td><td align="center" valign="top" rowspan="1" colspan="1">3.55 ± 0.80</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 ± 0.16</td><td align="center" valign="top" rowspan="1" colspan="1">5.71 ± 1.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">2.16 ± 0.74</td><td align="right" valign="top" rowspan="1" colspan="1">−0.23 ± 0.14</td><td align="right" valign="top" rowspan="1" colspan="1">−3.783<xref ref-type="table-fn" rid="tfn22-ehp-118-735">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">−1.852</td><td align="left" valign="top" rowspan="1" colspan="1">−5.798<xref ref-type="table-fn" rid="tfn22-ehp-118-735">*</xref></td></tr><tr><td colspan="10" align="left" valign="top" rowspan="1">Double-blind</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Total symptom score</td><td align="center" valign="top" rowspan="1" colspan="1">6.63 ± 1.65</td><td align="center" valign="top" rowspan="1" colspan="1">1.25 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">3.84 ± 0.88</td><td align="center" valign="top" rowspan="1" colspan="1">1.15 ± 0.19</td><td align="right" valign="top" rowspan="1" colspan="1">−2.78 ± 1.56</td><td align="right" valign="top" rowspan="1" colspan="1">−0.11 ± 0.21</td><td align="right" valign="top" rowspan="1" colspan="1">−1.266</td><td align="center" valign="top" rowspan="1" colspan="1">−0.637</td><td align="left" valign="top" rowspan="1" colspan="1">−1.291</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Total number of symptoms reported</td><td align="center" valign="top" rowspan="1" colspan="1">5.06 ± 1.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.91 ± 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">2.99 ± 0.67</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 ± 0.12</td><td align="right" valign="top" rowspan="1" colspan="1">−2.07 ± 1.03</td><td align="right" valign="top" rowspan="1" colspan="1"></td><td align="right" valign="top" rowspan="1" colspan="1">−1.578</td><td align="center" valign="top" rowspan="1" colspan="1">−0.640</td><td align="left" valign="top" rowspan="1" colspan="1">−1.363</td></tr></tbody></table><table-wrap-foot><fn id="tfn19-ehp-118-735"><label>a</label><p>Difference score: TETRA – sham; positive value indicates TETRA &gt; sham.</p></fn><fn id="tfn20-ehp-118-735"><label>b</label><p>Wilcoxon signed rank tests.</p></fn><fn id="tfn21-ehp-118-735"><label>c</label><p>Mann-Whitney <italic>U</italic>-tests.</p></fn><fn id="tfn22-ehp-118-735"><label>*</label><p><italic>p</italic> ≤ 0.001.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6-ehp-118-735" orientation="portrait" position="float"><label>Table 6</label><caption><p>Descriptives (means ± SEs for original untransformed data) and statistical tests (<italic>F</italic>-scores) for physiologic measures for sensitive and control participants by exposure during open provocation and double-blind tests.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">Test/measure</th><th colspan="2" align="center" valign="bottom" rowspan="1">Sham<hr></hr></th><th colspan="2" align="center" valign="bottom" rowspan="1">TETRA<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Condition</th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive vs. control</th><th align="center" valign="bottom" rowspan="2" colspan="1">Group × condition</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sensitive</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th></tr></thead><tbody><tr><td colspan="8" align="left" valign="top" rowspan="1">Open provocation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> BVP mean<xref ref-type="table-fn" rid="tfn24-ehp-118-735">a</xref></td><td align="right" valign="top" rowspan="1" colspan="1">36.02 ± 0.03</td><td align="right" valign="top" rowspan="1" colspan="1">36.10 ± 0.06</td><td align="right" valign="top" rowspan="1" colspan="1">36.01 ± 0.03</td><td align="right" valign="top" rowspan="1" colspan="1">36.13 ± 0.10</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> BVP SD<xref ref-type="table-fn" rid="tfn24-ehp-118-735">a</xref></td><td align="right" valign="top" rowspan="1" colspan="1">1.15 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">1.12 ± 0.09</td><td align="right" valign="top" rowspan="1" colspan="1">1.10 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">1.14 ± 0.11</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SC mean</td><td align="right" valign="top" rowspan="1" colspan="1">6.99 ± 0.58</td><td align="right" valign="top" rowspan="1" colspan="1">7.61 ± 0.44</td><td align="right" valign="top" rowspan="1" colspan="1">6.99 ± 0.55</td><td align="right" valign="top" rowspan="1" colspan="1">7.66 ± 0.45</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SC SD</td><td align="right" valign="top" rowspan="1" colspan="1">0.93 ± 0.11</td><td align="right" valign="top" rowspan="1" colspan="1">0.95 ± 0.07</td><td align="right" valign="top" rowspan="1" colspan="1">0.94 ± 0.12</td><td align="right" valign="top" rowspan="1" colspan="1">0.99 ± 0.08</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> HR mean</td><td align="right" valign="top" rowspan="1" colspan="1">71.78 ± 1.50</td><td align="right" valign="top" rowspan="1" colspan="1">67.58 ± 0.88</td><td align="right" valign="top" rowspan="1" colspan="1">71.66 ± 1.46</td><td align="right" valign="top" rowspan="1" colspan="1">66.94 ± 0.88</td><td align="left" valign="top" rowspan="1" colspan="1">2.11</td><td align="center" valign="top" rowspan="1" colspan="1">7.16<xref ref-type="table-fn" rid="tfn26-ehp-118-735">**</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> HR SD<xref ref-type="table-fn" rid="tfn24-ehp-118-735">a</xref></td><td align="right" valign="top" rowspan="1" colspan="1">7.46 ± 0.73</td><td align="right" valign="top" rowspan="1" colspan="1">7.11 ± 0.59</td><td align="right" valign="top" rowspan="1" colspan="1">7.00 ± 0.78</td><td align="right" valign="top" rowspan="1" colspan="1">6.84 ± 0.54</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td colspan="8" align="left" valign="top" rowspan="1">Double-blind</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> BVP mean<xref ref-type="table-fn" rid="tfn24-ehp-118-735">a</xref></td><td align="right" valign="top" rowspan="1" colspan="1">36.30 ± 0.14</td><td align="right" valign="top" rowspan="1" colspan="1">36.71 ± 0.49</td><td align="right" valign="top" rowspan="1" colspan="1">36.23 ± 0.08</td><td align="right" valign="top" rowspan="1" colspan="1">36.16 ± 0.06</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> BVP SD</td><td align="right" valign="top" rowspan="1" colspan="1">1.19 ± 0.09</td><td align="right" valign="top" rowspan="1" colspan="1">1.58 ± 0.35</td><td align="right" valign="top" rowspan="1" colspan="1">1.17 ± 0.12</td><td align="right" valign="top" rowspan="1" colspan="1">1.27 ± 0.08</td><td align="left" valign="top" rowspan="1" colspan="1">0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SC mean</td><td align="right" valign="top" rowspan="1" colspan="1">9.50 ± 0.88</td><td align="right" valign="top" rowspan="1" colspan="1">8.87 ± 0.47</td><td align="right" valign="top" rowspan="1" colspan="1">8.84 ± 0.74</td><td align="right" valign="top" rowspan="1" colspan="1">7.98 ± 0.40</td><td align="left" valign="top" rowspan="1" colspan="1">1.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td><td align="center" valign="top" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> SC SD</td><td align="right" valign="top" rowspan="1" colspan="1">1.63 ± 0.13</td><td align="right" valign="top" rowspan="1" colspan="1">1.68 ± 0.09</td><td align="right" valign="top" rowspan="1" colspan="1">1.62 ± 0.11</td><td align="right" valign="top" rowspan="1" colspan="1">1.49 ± 0.09</td><td align="left" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td><td align="center" valign="top" rowspan="1" colspan="1">3.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> HR mean</td><td align="right" valign="top" rowspan="1" colspan="1">77.01 ± 1.32</td><td align="right" valign="top" rowspan="1" colspan="1">73.51 ± 1.08</td><td align="right" valign="top" rowspan="1" colspan="1">77.07 ± 1.29</td><td align="right" valign="top" rowspan="1" colspan="1">72.69 ± 0.91</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="center" valign="top" rowspan="1" colspan="1">5.59<xref ref-type="table-fn" rid="tfn25-ehp-118-735">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> HR SD</td><td align="right" valign="top" rowspan="1" colspan="1">9.40 ± 0.79</td><td align="right" valign="top" rowspan="1" colspan="1">8.83 ± 0.59</td><td align="right" valign="top" rowspan="1" colspan="1">10.63 ± 1.16</td><td align="right" valign="top" rowspan="1" colspan="1">8.23 ± 0.47</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="center" valign="top" rowspan="1" colspan="1">3.17</td><td align="center" valign="top" rowspan="1" colspan="1">1.11</td></tr></tbody></table><table-wrap-foot><fn id="tfn23-ehp-118-735"><p>NA, not applicable. Nonparametric statistics were also performed on the untransformed data with virtually the same results (copies of this analysis are available upon request).</p></fn><fn id="tfn24-ehp-118-735"><label>a</label><p>These data did not lend themselves to transformation because participants’ scores were tightly grouped around the mean; therefore, ANOVAs were not conducted on these data.</p></fn><fn id="tfn25-ehp-118-735"><label>*</label><p><italic>p</italic> ≤ 0.05.</p></fn><fn id="tfn26-ehp-118-735"><label>**</label><p><italic>p</italic> ≤ 0.01.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t7-ehp-118-735" orientation="portrait" position="float"><label>Table 7</label><caption><p>Successful and failed judgments by trial for sensitive and control participants [<italic>n</italic> (%)].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">Trial</th><th colspan="3" align="center" valign="bottom" rowspan="1">Sensitive (<italic>n</italic>= 50)<hr></hr></th><th colspan="3" align="center" valign="bottom" rowspan="1">Control (<italic>n</italic>= 132)<hr></hr></th><th align="center" valign="bottom" rowspan="2" colspan="1">Sensitive vs. control χ<sup>2</sup><xref ref-type="table-fn" rid="tfn27-ehp-118-735">a</xref></th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Correct</th><th align="center" valign="bottom" rowspan="1" colspan="1">Incorrect</th><th align="center" valign="bottom" rowspan="1" colspan="1">χ<sup>2</sup><xref ref-type="table-fn" rid="tfn27-ehp-118-735">a</xref></th><th align="center" valign="bottom" rowspan="1" colspan="1">Correct</th><th align="center" valign="bottom" rowspan="1" colspan="1">Incorrect</th><th align="center" valign="bottom" rowspan="1" colspan="1">χ<sup>2</sup><xref ref-type="table-fn" rid="tfn27-ehp-118-735">a</xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 1<xref ref-type="table-fn" rid="tfn28-ehp-118-735">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">26 (52.0)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (48.0)</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">66 (50.0)</td><td align="center" valign="top" rowspan="1" colspan="1">66 (50.0)</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 2<xref ref-type="table-fn" rid="tfn28-ehp-118-735">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">28 (56.0)</td><td align="center" valign="top" rowspan="1" colspan="1">22 (44.0)</td><td align="left" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1">61 (46.2)</td><td align="center" valign="top" rowspan="1" colspan="1">71 (53.8)</td><td align="left" valign="top" rowspan="1" colspan="1">0.54</td><td align="center" valign="top" rowspan="1" colspan="1">1.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 3<xref ref-type="table-fn" rid="tfn28-ehp-118-735">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">31 (62.0)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (38.0)</td><td align="left" valign="top" rowspan="1" colspan="1">2.17</td><td align="center" valign="top" rowspan="1" colspan="1">55 (41.7)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (58.3)</td><td align="left" valign="top" rowspan="1" colspan="1">3.82<xref ref-type="table-fn" rid="tfn31-ehp-118-735">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5.23<xref ref-type="table-fn" rid="tfn31-ehp-118-735">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 4<xref ref-type="table-fn" rid="tfn28-ehp-118-735">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">25 (50.0)</td><td align="center" valign="top" rowspan="1" colspan="1">25 (50.0)</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">55 (41.7)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (58.3)</td><td align="left" valign="top" rowspan="1" colspan="1">2.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 5<xref ref-type="table-fn" rid="tfn29-ehp-118-735">c</xref>,<xref ref-type="table-fn" rid="tfn30-ehp-118-735">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">22 (45.8)</td><td align="center" valign="top" rowspan="1" colspan="1">26 (54.2)</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td align="center" valign="top" rowspan="1" colspan="1">72 (54.5)</td><td align="center" valign="top" rowspan="1" colspan="1">60 (45.5)</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trial 6<xref ref-type="table-fn" rid="tfn29-ehp-118-735">c</xref>,<xref ref-type="table-fn" rid="tfn30-ehp-118-735">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">16 (33.3)</td><td align="center" valign="top" rowspan="1" colspan="1">32 (66.7)</td><td align="left" valign="top" rowspan="1" colspan="1">4.2<xref ref-type="table-fn" rid="tfn31-ehp-118-735">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">69 (52.3)</td><td align="center" valign="top" rowspan="1" colspan="1">63 (47.7)</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td><td align="center" valign="top" rowspan="1" colspan="1">4.34<xref ref-type="table-fn" rid="tfn31-ehp-118-735">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn27-ehp-118-735"><label>a</label><p>Values reflect χ<sup>2</sup> with Yates continuity corrections. <italic>p</italic>-Values with or without the correction are very similar.</p></fn><fn id="tfn28-ehp-118-735"><label>b</label><p>Duration of exposure, 5 min.</p></fn><fn id="tfn29-ehp-118-735"><label>c</label><p>Duration of exposure, 50 min.</p></fn><fn id="tfn30-ehp-118-735"><label>d</label><p>Sensitive group: <italic>n</italic> = 48 for sessions 2 and 3.</p></fn><fn id="tfn31-ehp-118-735"><label>*</label><p><italic>p</italic> ≤ 0.05.</p></fn></table-wrap-foot></table-wrap></floats-group></article>